Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7404018778514333,-2.1502699332978867,0.0,0.008197950800756911,0.007,11/19,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;GRIA2;GRM3;GRIA1;GRIN2D;GRIK2;GRM5
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6378984136470949,-2.105910074733826,0.0,0.005855679143397794,0.009,15/29,22.19%,GRID2;GRIK4;GABRA2;GABRB1;GLRA3;GABRG3;GRIA2;GABRA5;GABRB2;GRIN2D;GRIK2;CHRNB1;GLRA2;GABRG1;GABRE
prerank,chemokine activity (GO:0008009),0.8031421232715196,1.9997750746016967,0.0,0.007541571366755269,0.007,8/31,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,chemokine receptor binding (GO:0042379),0.781204638409821,1.9753720265974113,0.0,0.007541571366755269,0.015,8/35,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,platelet-derived growth factor binding (GO:0048407),0.957167325881302,1.9526518234017014,0.0,0.010369660629288496,0.028,7/11,2.67%,COL4A1;COL1A2;COL1A1;COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,serine-type endopeptidase activity (GO:0004252),0.6823858304305576,1.9457552158744609,0.0,0.009191290103232984,0.031,8/80,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;PLAT
prerank,metalloendopeptidase activity (GO:0004222),0.6586236422247447,1.8780432519255221,0.0,0.03242875687704766,0.135,24/76,12.77%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;MMP11;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,GABA receptor activity (GO:0016917),-0.5848550911887519,-1.876441912272442,0.0034482758620689655,0.1128194181627975,0.234,6/21,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GPR156;GABRB2
prerank,serine-type peptidase activity (GO:0008236),0.6395625002949586,1.8676931959852232,0.0,0.03362283901011725,0.17,9/96,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;HTRA3;PLAT
prerank,monocarboxylic acid binding (GO:0033293),0.8002100582097971,1.8574616654836842,0.001445086705202312,0.03528378032303358,0.197,3/18,5.34%,NR1H4;NR2F2;PYGL
prerank,lipoprotein particle receptor binding (GO:0070325),0.741546421650776,1.8500649182029465,0.0,0.03511544167645422,0.22,5/27,3.78%,CLTC;LRP1;HSPG2;CRP;APOE
prerank,endopeptidase activity (GO:0004175),0.5900674710179948,1.8055052070834718,0.0,0.07300660059206143,0.428,47/257,10.17%,PSMA7;MMP3;MMP13;FAP;MMP27;CASP4;HP;HPR;MMP2;MMP14;ADAM19;ADAMTS2;MASP1;PRTN3;PDIA3;CASP1;MMP11;USP9X;KLK2;CTSS;ADAMTS15;ADAMTS5;OMA1;SFRP1;HTRA3;PLAT;ADAMTS4;CTSK;ADAMTS14;CTSL;ADAMTS12;ADAMTS1;TPP2;ADAMTS9;USP42;ADAMTS18;PMPCB;USP24;PSMB8;MMP16;HTRA4;PSMA6;NLN;USP12;CTSB;USP40;USP38
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5916257440951154,-1.805008144547136,0.006688963210702341,0.19177349194627774,0.448,9/19,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,semaphorin receptor binding (GO:0030215),-0.5685852263921521,-1.801480740224137,0.004048582995951417,0.15810333687174044,0.46,17/23,29.80%,SEMA6A;SEMA3C;SEMA3D;RIT2;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5681266385324009,-1.8003123577594544,0.008403361344537815,0.13311910585990985,0.464,12/26,12.26%,ABCG2;SLC6A6;MPC1;SLC6A1;SLC6A12;SLC16A11;SLC5A6;SLC16A1;SLC27A1;SLC16A9;SLC16A4;MPC2
prerank,GABA-A receptor activity (GO:0004890),-0.584632985263126,-1.7994412534881883,0.003246753246753247,0.11477131121059675,0.466,5/18,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.8190398692914274,1.7839159658424828,0.006042296072507553,0.08889627248562774,0.549,3/13,3.47%,SLC7A2;SLC38A3;SLC7A7
prerank,CXCR chemokine receptor binding (GO:0045236),0.8711742250068282,1.7788055452070235,0.0,0.08707086941617447,0.572,5/11,6.48%,CXCL5;CXCL1;CXCL12;CXCL10;YARS1
prerank,cytokine activity (GO:0005125),0.5931689761105198,1.7585018722637877,0.0,0.10872432053738847,0.679,26/131,12.48%,CCL11;CXCL5;CCL7;IL34;ADIPOQ;WNT2;CXCL1;CXCL12;TNFSF11;IL16;TIMP1;XCL1;WNT9A;TSLP;CCL5;TGFB3;CXCL10;INHBB;AIMP1;WNT5A;IL7;BMP5;CCL2;TGFB2;TNF;FGF2
prerank,cholesterol transfer activity (GO:0120020),0.7818845723655522,1.7576256491078288,0.0029542097488921715,0.1016661832326047,0.683,6/16,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.718403973086059,1.7340918533104843,0.006830601092896175,0.13238151167000767,0.801,4/22,3.78%,CLTC;HSPG2;CRP;APOE
prerank,triglyceride lipase activity (GO:0004806),0.7397998931678335,1.7293794908662738,0.002805049088359046,0.13172611320599206,0.823,2/20,1.54%,CEL;LIPC
prerank,metallopeptidase activity (GO:0008237),0.5841084396385795,1.7281434947940006,0.0,0.12608564628793964,0.828,30/113,12.77%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;ADAM12;MMP11;ANPEP;BMP1;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;EIF3H;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;PAPPA2;ADAM21;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6490027462775162,-1.7233948044024627,0.008174386920980926,0.2036312422116583,0.724,5/12,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,CCR chemokine receptor binding (GO:0048020),0.6941531317183149,1.7021921987274966,0.0025575447570332483,0.16552640095415058,0.918,4/28,5.67%,CCL11;CCL7;XCL1;CCL5
prerank,steroid hydroxylase activity (GO:0008395),0.7420082180983291,1.6992393466871607,0.016129032258064516,0.1619866683150976,0.922,5/16,12.52%,CYP1B1;CYP7B1;CYP2A6;CYP1A1;CYP2R1
prerank,sterol transfer activity (GO:0120015),0.7357053243545026,1.6638375804083092,0.01032448377581121,0.23602141441878172,0.97,6/17,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6006857605275483,-1.6617192092131101,0.006756756756756757,0.3159464213371076,0.894,8/16,25.76%,SLC26A7;SLC26A2;SLC1A1;CLCN7;SLC4A8;SLC26A6;CFTR;SLC26A8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7896512353535295,1.6493473541063624,0.008025682182985553,0.2632951103418434,0.984,2/11,7.31%,ROR2;SASH1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6026986332703208,-1.6458934987090184,0.0189873417721519,0.32335060229842616,0.928,8/15,25.76%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC4A3;SLC26A6;CFTR;SLC26A8
prerank,E-box binding (GO:0070888),0.6335082652866276,1.645859452623717,0.006361323155216285,0.2610371279623922,0.985,8/34,7.47%,ZEB1;TCF4;SNAI1;SNAI2;MITF;PPARG;AHR;BHLHE40
prerank,metalloaminopeptidase activity (GO:0070006),0.7380675715542215,1.6448843090023937,0.02282453637660485,0.25187134371470155,0.985,9/16,14.50%,MMP14;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,ligand-gated ion channel activity (GO:0015276),-0.49278328043172903,-1.6426511841535938,0.019305019305019305,0.3026853782669077,0.931,10/30,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.49338596790937905,-1.6386540691925549,0.016666666666666666,0.28419562775957297,0.935,9/28,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,ligand-gated channel activity (GO:0022834),-0.496423837181204,-1.6352504929993317,0.023076923076923078,0.2691810658534247,0.938,10/29,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.7402435612247952,1.631638275368944,0.015220700152207,0.2781364309500069,0.994,7/15,16.10%,SH3PXD2B;SESTD1;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,cytokine receptor binding (GO:0005126),0.566028818477881,1.6264213388601296,0.0065005417118093175,0.28198406688508376,0.997,22/83,15.48%,IL34;IL23R;OSMR;CXCL12;TNFSF11;JAK1;JAK2;XCL1;SPRED1;SMAD2;TSLP;SPRED2;CCL5;PXDN;LIFR;TGFB2;TGFBRAP1;VEGFC;SMAD3;IL22;IL6R;TIMM50
prerank,anion channel activity (GO:0005253),-0.40770511799028025,-1.6242566880315488,0.0072992700729927005,0.27571883509484474,0.955,16/61,9.33%,SLC26A7;LRRC8D;GABRA2;GABRB1;GLRA3;GABRG3;GPR89B;GPR89A;GABRA5;GLRA1;CLCN3;VDAC1;GABRB2;ANO3;CLCC1;CLCN7
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7792557958887603,1.6234849237412212,0.022082018927444796,0.2788118934289423,0.997,4/11,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7918358822469455,1.6208970211140947,0.0210016155088853,0.2747597491214973,0.997,4/10,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,poly(U) RNA binding (GO:0008266),0.7005457855826109,1.6196195939428155,0.024355300859598854,0.2679352716133331,0.997,5/20,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,PDZ domain binding (GO:0030165),-0.4290461063784878,-1.6158278123318879,0.007462686567164179,0.2770126613436716,0.967,21/61,8.95%,CRIM1;GRID2;TGFBR3;ARHGAP29;CADM1;PRKN;CIT;CXADR;KIDINS220;RAPGEF2;ATP2B4;ATP2B2;DOCK4;USHBP1;PLEKHA1;GRIA1;FZD4;CLCN3;NSF;SLC22A4;CRIPT
prerank,chloride channel activity (GO:0005254),-0.41367507134526604,-1.6040032811475449,0.0,0.2858303381871048,0.976,24/59,25.76%,SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;CLCC1;CLCN7;CLIC4;ANO4;TTYH2;ANO1;GLRA2;FXYD1;GABRG1;GABRE;ANO2;CFTR;SLC26A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.79711194177352,1.6017773139678093,0.023923444976076555,0.3100461192698628,1.0,4/10,5.37%,APOBEC1;LACC1;CDADC1;GDA
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5875128720653316,-1.5962018439827685,0.021021021021021023,0.2867904973407649,0.983,9/15,15.70%,HS3ST3A1;HS3ST1;HS6ST2;HS6ST3;NDST3;NDST1;HS6ST1;HS3ST2;HS3ST3B1
prerank,protease binding (GO:0002020),0.5488318131926152,1.5883501661143349,0.0032292787944025836,0.3401508740591687,1.0,17/99,8.75%,FAP;COL1A2;COL1A1;COL3A1;CLTC;CCBE1;SLC2A13;TIMP1;TNFAIP3;CFLAR;PTEN;BCL2;ADAMTS4;BAG6;PZP;ITGA3;RAD23A
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.6554087722797917,1.572084859781225,0.03089887640449438,0.3818234736560137,1.0,6/22,8.81%,RBMS3;ZFP36L1;ZFP36L2;ILF3;CPEB1;EXOSC4
prerank,ligand-gated anion channel activity (GO:0099095),-0.5274580655748743,-1.564471366953784,0.01607717041800643,0.3409957154505315,0.992,7/17,8.10%,GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;GLRA1;GABRB2
prerank,MHC class II protein complex binding (GO:0023026),-0.6337326060009126,-1.5574656829088025,0.047493403693931395,0.33901300303881965,0.993,4/11,3.44%,ATP1B1;CD81;ANXA11;HSP90AA1
prerank,aminopeptidase activity (GO:0004177),0.6452224136474418,1.5574590677624673,0.03074866310160428,0.4185876204168802,1.0,10/26,14.50%,MMP14;XPNPEP2;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,calcium-release channel activity (GO:0015278),0.6880085115064511,1.55221791781502,0.040238450074515646,0.4247141968535575,1.0,6/17,12.14%,MCOLN2;RASA3;ITPR1;PKD2;FKBP1B;TPCN2
prerank,cytokine receptor activity (GO:0004896),0.5250691191239494,1.5249235410420334,0.01670378619153675,0.5208540557956395,1.0,9/83,7.36%,IL23R;IL1RL2;OSMR;GHR;CMKLR1;IL1R1;CCR1;IL3RA;IFNAR2
prerank,peptidoglycan binding (GO:0042834),0.7340420063171713,1.5132791992119479,0.0625,0.555719540087779,1.0,3/10,5.65%,TLR2;NOD1;RNASE7
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4331180161463635,-1.5098202074150087,0.01694915254237288,0.4476666705127613,0.998,14/37,16.35%,SLC22A8;SLCO1C1;COX5A;COX8A;SLC22A6;SLCO3A1;COX4I1;SLCO2A1;SLC22A4;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5709959414716971,-1.4991534055540578,0.04421768707482993,0.45607375271149675,0.999,8/15,16.35%,COX5A;COX8A;COX4I1;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,neurexin family protein binding (GO:0042043),0.748536176709641,1.4978538743658085,0.04,0.6097360450021636,1.0,1/10,0.08%,CEL
prerank,poly-pyrimidine tract binding (GO:0008187),0.6315239260966484,1.4912703796382014,0.05454545454545454,0.6235413103651962,1.0,5/23,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,retinoic acid receptor binding (GO:0042974),0.6547311936939764,1.4907184065162689,0.08071748878923767,0.6096952797515325,1.0,5/17,5.97%,NRIP1;ASXL1;TACC1;ARID5A;PPARG
prerank,anion transmembrane transporter activity (GO:0008509),-0.5884533886732588,-1.4890103774509982,0.06944444444444445,0.46211955130760224,0.999,3/12,5.49%,ABCG2;SLC22A6;SLC39A8
prerank,growth factor receptor binding (GO:0070851),0.5166289621217084,1.4882546789202364,0.014973262032085561,0.6043180213623631,1.0,25/95,16.56%,GLMN;IL23R;PDGFRA;IL1R1;PDGFRB;FGF7;JAK2;ATXN2;TSLP;EGF;GRB2;FRS2;PTPRJ;ARF4;SNX2;VEGFC;FGF2;BTC;ITGA5;PSEN1;SRC;IL6R;TIMM50;FGF18;SNX4
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5247329341653132,-1.4852502430150911,0.0625,0.4524657814628939,0.999,7/17,15.65%,GRIK4;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2
prerank,AMP binding (GO:0016208),-0.5982818186261344,-1.4804578563486852,0.06989247311827956,0.44712989992461655,0.999,2/11,0.10%,PRKAG2;MPPED2
prerank,phosphatase inhibitor activity (GO:0019212),0.6392695250617347,1.4794248705156823,0.05370101596516691,0.6263371706902646,1.0,3/20,1.92%,MGAT5;PPP1R9B;PTN
prerank,sterol binding (GO:0032934),0.5451659000459037,1.4761774127778833,0.03225806451612903,0.626068260493293,1.0,13/56,11.03%,RORA;ABCA1;APOD;INSIG2;ABCG1;OSBPL11;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6621717097981575,1.4748449784604099,0.06676783004552352,0.6166614148060254,1.0,2/15,4.31%,CMKLR1;CCR1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5924412125546662,1.4679832807980886,0.06266666666666666,0.6329982014441432,1.0,6/26,13.24%,MGAT5;PPP1R9B;PTN;PABIR1;PPP1R2;PPME1
prerank,CARD domain binding (GO:0050700),0.6706756441602539,1.4661814689890322,0.07317073170731707,0.6259942697858429,1.0,3/14,5.14%,CASP4;CASP1;NOD1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6016792339518341,-1.4658483236847446,0.0664819944598338,0.47046868509715234,1.0,6/11,30.28%,KCND3;KCNJ3;KCNQ1;KCNE4;KCNJ8;KCNH2
prerank,alkali metal ion binding (GO:0031420),-0.5478123902492849,-1.4635578581998692,0.08771929824561403,0.4593555069566977,1.0,3/13,11.89%,ATP1A2;HDAC4;PDXK
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5115999638768156,1.4632188264787098,0.026519337016574586,0.6242792797855541,1.0,22/78,13.19%,CASP4;PDIA3;CFLAR;CASP1;USP9X;CASP12;CTSS;SFRP1;CAPN5;CTSK;CTSL;CAPN2;CAPN15;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5609283636052844,-1.4596958115944578,0.08358208955223881,0.4523620576777451,1.0,3/13,3.01%,BMP6;BMP4;CDH5
prerank,ubiquitin-specific protease binding (GO:1990381),0.621873554228754,1.4492382553251122,0.0708092485549133,0.6725615242491054,1.0,6/19,14.19%,CLTC;PTEN;BAG6;RAD23A;LCOR;RHBDD2
prerank,frizzled binding (GO:0005109),0.5677003146854062,1.4476228730251182,0.05897114178168131,0.664723937098027,1.0,6/34,9.14%,WNT2;WNT9A;FZD1;SFRP1;LRP6;WNT5A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.569982274610429,-1.4426350749990873,0.06493506493506493,0.4820896986200212,1.0,5/10,22.19%,GABRA2;GABRG3;GABRA5;GABRG1;GABRE
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.39767304890005156,-1.4415406978016432,0.02824858757062147,0.4686158674481931,1.0,14/42,12.02%,LRRC4C;STXBP6;BSG;NTNG1;CNTN4;CD47;ESAM;TMOD3;BAIAP2L1;DSCAML1;CD200;PDLIM5;NEXN;ROBO4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5650631304912771,1.437758914250849,0.07142857142857142,0.6949277211275794,1.0,6/38,8.82%,SERPING1;TFPI2;SERPINE2;SERPINH1;SERPINF1;SERPINA2
prerank,chloride channel inhibitor activity (GO:0019869),-0.5903259139738851,-1.4365814613057908,0.0896358543417367,0.46611205981446435,1.0,5/10,24.45%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,anion:anion antiporter activity (GO:0015301),-0.5038911258909765,-1.4348104196891198,0.06832298136645963,0.45576073023194186,1.0,4/17,10.82%,SLC26A7;SLC26A2;SLC25A4;SLC4A3
prerank,neuropeptide receptor binding (GO:0071855),0.6585901577542181,1.4322108210045996,0.09259259259259259,0.7055886314932723,1.0,1/14,0.47%,QRFP
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6567278528815585,1.4321197629048208,0.084070796460177,0.6914582053381407,1.0,5/15,12.81%,KMT2A;CXXC1;RBBP5;SETMAR;KMT2B
prerank,cell adhesion mediator activity (GO:0098631),-0.4533328925663678,-1.431537042753334,0.08527131782945736,0.45008213815941295,1.0,9/24,12.02%,LRRC4C;BSG;NTNG1;CNTN4;CD47;ESAM;DSCAML1;NEXN;ROBO4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4504046348930214,-1.4267798531355327,0.07553956834532374,0.4468770410525153,1.0,10/25,12.16%,NOS3;MICAL3;FMO2;CYP26B1;FMO5;MSMO1;FMO1;CYP27A1;MICAL1;SQLE
prerank,mRNA 5'-UTR binding (GO:0048027),0.592721853500719,1.4247923900730264,0.09861111111111111,0.7109250788156024,1.0,3/24,2.23%,IGF2BP1;IGF2BP2;SYNCRIP
prerank,BMP receptor binding (GO:0070700),-0.5609302397105114,-1.422972296935064,0.09169054441260745,0.44358491769809877,1.0,3/12,3.01%,BMP6;BMP4;CDH5
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5814935253726446,1.4200062476550286,0.08678756476683938,0.7208300455621451,1.0,11/28,16.63%,TNFSF11;STAT1;CASP8AP2;SIVA1;BABAM2;EDA;TRAP1;TNF;TRAF2;RIPK1;TRAF5
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5934543451298836,1.410541735113336,0.091164095371669,0.7515828502955288,1.0,9/23,15.97%,SH3PXD2B;WIPI1;SESTD1;MAPKAP1;GBF1;KIF16B;PLEKHA5;WDR45;PLA2G4E
prerank,adenylate cyclase binding (GO:0008179),-0.5868074554264779,-1.4091260383330682,0.09487179487179487,0.4661789818618175,1.0,5/10,4.54%,ADCY5;AKAP6;CALM1;AKAP12;CAP1
prerank,receptor antagonist activity (GO:0048019),0.6132071825455343,1.4091145942922716,0.10014727540500737,0.7438230494960817,1.0,4/17,8.73%,CCL5;DKK2;WFIKKN1;PXDN
prerank,I-SMAD binding (GO:0070411),0.6516181074785723,1.4070730350384641,0.09792284866468842,0.7394580554468049,1.0,8/13,15.51%,SMAD2;TGFBR1;SMAD5;TGFB1I1;SMAD3;SMAD4;SMAD1;SMURF1
prerank,Toll-like receptor binding (GO:0035325),0.6753541631164259,1.405719946625211,0.10091743119266056,0.7319780608832968,1.0,3/11,7.77%,TLR2;CD36;TIRAP
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6350663528342331,1.4048790550655392,0.1126331811263318,0.7224421356599757,1.0,5/14,18.95%,AKR1A1;RDH12;RDH10;ADH1A;DHRS3
prerank,actinin binding (GO:0042805),0.5965992876056664,1.4048423789155606,0.10136986301369863,0.7098834819632378,1.0,6/21,8.37%,CSRP1;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,phospholipid transfer activity (GO:0120014),-0.48416031020700523,-1.404764698401831,0.07604562737642585,0.4656891496541079,1.0,6/21,9.97%,PITPNC1;CERT1;PITPNM2;PITPNA;ABCA3;TNFAIP8L3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.46596172666175895,1.4038008478580117,0.018367346938775512,0.7020325259574577,1.0,29/173,10.21%,CREB3L1;TRPS1;ZEB2;POU5F1;ZEB1;ETV6;DEAF1;SNAI1;TBX18;BCL6;BACH1;SNAI2;MITF;TBX2;PRDM5;PRDM2;FOXK2;PPARG;ENO1;E2F8;ZBTB12;BHLHE40;HEYL;ZBTB5;FOXO3;FOXP4;PRDM1;NR2F1;TBX3
prerank,hormone activity (GO:0005179),0.5131782686567569,1.4037935436317763,0.07052023121387284,0.6901496474907355,1.0,7/54,14.33%,QRFP;ADIPOQ;EDN3;INHBB;HCRT;INSL6;NPY
prerank,nuclear receptor binding (GO:0016922),0.47340300120217393,1.3981715736760207,0.027867095391211148,0.7034086460200697,1.0,44/111,22.80%,NR1H4;NCOR2;TCF7L2;NRIP1;ASXL1;DNAAF4;STAT1;WIPI1;TACC1;PADI2;ARID5A;PPID;TAF7;STRN;GTF2H1;TGFB1I1;OASL;RERG;CALR;LCOR;MED13;SMAD3;HMGN3;MMS19;BAZ2A;HIF1A;STAT5B;NSD1;SMARCA4;THRAP3;ZBTB7A;BCAS3;KDM1A;MED12;MED1;TMF1;FOXP1;TADA3;RNF14;PKN1;LATS1;MED14;NCOR1;SMARCD3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6594733396863813,1.3980251705411002,0.13343328335832083,0.6924646102491191,1.0,7/12,16.63%,TNFSF11;STAT1;BABAM2;TRAP1;TNF;TRAF2;TRAF5
prerank,protein tyrosine kinase activity (GO:0004713),0.4775115460708647,1.3954710918517463,0.04118268215417107,0.6919695824617587,1.0,18/108,8.07%,ROR2;ROR1;EPHA7;PDGFRA;TEC;JAK1;PEAK1;PDGFRB;JAK2;EGFR;EPHB3;BLK;DDR2;EPHA1;STYK1;HIPK4;MERTK;FRK
prerank,alpha-actinin binding (GO:0051393),0.5875651024889691,1.3938248801357949,0.09876543209876543,0.6883479484394364,1.0,6/24,8.37%,PALLD;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,hyaluronic acid binding (GO:0005540),0.6835603766210082,1.393714780048395,0.12788906009244994,0.6780049414291895,1.0,1/10,0.40%,CEMIP
prerank,lipase activity (GO:0016298),0.5322790189353133,1.3935787519428662,0.06985294117647059,0.6679511747447705,1.0,3/43,1.54%,CEL;PLA1A;LIPC
prerank,low-density lipoprotein particle binding (GO:0030169),0.6312228534860225,1.3918276410250883,0.10647482014388489,0.6649866252311081,1.0,6/16,5.55%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5623564104169311,-1.3896873172467465,0.10893854748603352,0.4934280117104228,1.0,3/10,5.87%,CD47;CXADR;CD200
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6621038032095456,1.3886891060927211,0.1261682242990654,0.6677386080661782,1.0,5/12,13.29%,GAB2;IRS1;SH2B2;FRS2;PIK3R1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5361865499760026,1.3884057694142427,0.09057527539779682,0.6590557036315176,1.0,13/34,17.85%,MYO1B;MYO10;GAB2;CYTH3;DAPP1;MAPKAP1;GBF1;OGT;KIF16B;PLA2G4E;ARHGAP9;AKT1;ZFYVE16
prerank,hexosaminidase activity (GO:0015929),0.6586432519391926,1.387252497956797,0.1062215477996965,0.6541903292651134,1.0,2/12,5.03%,CEMIP;CEMIP2
prerank,myosin II binding (GO:0045159),-0.5678237814921244,-1.3869062426235523,0.10209424083769633,0.48746987900591005,1.0,4/10,4.91%,SHROOM4;GSN;STXBP5L;TRIOBP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.45881842556984515,1.3858447069923128,0.024242424242424242,0.6505413329330002,1.0,55/188,18.79%,RUNX1;CREB3L1;POU5F1;YAP1;TCF7L2;TBX18;SOX5;CREB3L3;GATA6;ARID5B;STAT3;RBBP5;ARID5A;PRDM5;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;AHR;IRF1;CARM1;CREB3L2;AHRR;NONO;FOXO3;TBL1X;HMGB2;TCF7;LIN54;NFE2L2;ARID4B;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;SMAD4;MAFK;GABPB1;BNC2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PAX8;HDAC5;SOX2;HINFP;ARID4A
prerank,retinoid binding (GO:0005501),-0.44398811466503296,-1.3799940329502338,0.08333333333333333,0.4928079508835959,1.0,5/22,7.84%,PTGDS;RBP4;ABCA4;CYP26B1;CRABP2
prerank,SH2 domain binding (GO:0042169),0.5508154452749755,1.377253479809709,0.08657465495608532,0.6753689597559394,1.0,8/31,11.01%,DLC1;SH3PXD2B;IRS1;JAK2;KHDRBS1;SH2B2;LAT2;PTK2
prerank,transcription corepressor binding (GO:0001222),0.5559568429303248,1.3756368677197726,0.1126005361930295,0.6721818270795986,1.0,4/27,6.40%,RORA;NEK6;PHF1;EHMT1
prerank,transforming growth factor beta binding (GO:0050431),0.5706322620799901,1.3727404985420946,0.11303191489361702,0.6746865370333833,1.0,7/23,9.75%,LTBP3;ACVR1;CD36;TGFB3;WFIKKN1;TGFBR1;LTBP1
prerank,transcription cis-regulatory region binding (GO:0000976),0.4464770452219842,1.3724985933775233,0.0,0.6664608912553526,1.0,99/406,18.89%,RORA;RUNX1;NR1H4;CREB3L1;TRPS1;RUNX3;POU5F1;ETV6;YAP1;DEAF1;TCF7L2;SNAI1;TBX18;SOX5;GLI3;CREB3L3;SATB2;GATA6;SNAI2;NPAS4;ARID5B;SMAD2;STAT3;RBBP5;ZBTB10;ARID5A;E2F1;PRDM5;PRDM2;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;ENO1;AHR;MLXIP;E2F8;ARNT;IRF1;CARM1;CREB3L2;SNAPC3;AHRR;HDAC1;ZBTB5;NONO;FOXO3;TBL1X;HMGB2;TCF7;TEAD1;FOXN2;KLF10;BBX;NFE2L2;SP3;ARID4B;E2F3;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;GABPB1;SETX;BNC2;CREB3;HIF1A;MAX;NFXL1;TCF3;SREBF1;POLRMT;CALCOCO1;MZF1;ZNF25;ATF4;TAF2;GLI1;ETS1;ZNF3;LHX6;PAX8;ZBTB9;HDAC5;NR2C2;SOX2;HINFP;ARID4A;NR3C1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4432172259989657,1.3714098512026576,0.001,0.6617351795759412,1.0,179/730,18.68%,RORA;RUNX1;NR1H4;RUNX2;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;CREB3L2;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.495868577600388,1.3678053132825818,0.08013937282229965,0.6669329099468706,1.0,15/60,12.55%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;DDR2;ACVR1;EPHA1;MERTK;ACVR1B;FGFR1;ACVR2A;NTRK3
prerank,sialyltransferase activity (GO:0008373),-0.45907806175658966,-1.3655752578317957,0.09615384615384616,0.5180519338164028,1.0,8/20,12.49%,ST3GAL6;ST6GALNAC3;ST8SIA4;ST3GAL4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5098208176346619,1.3623406639422817,0.11138310893512852,0.6783374102561838,1.0,18/42,19.95%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;FBXW7;GRB2;SHB;VAV1;PIK3R1;NEDD4;YES1;RASA1;PTPN5;YWHAE;SHD;PIN1
prerank,estrogen receptor binding (GO:0030331),0.5294738650767473,1.3613855379196287,0.12612612612612611,0.6733269615138935,1.0,12/32,16.10%,NRIP1;DNAAF4;WIPI1;TACC1;PADI2;ARID5A;PPID;STRN;RERG;LCOR;MMS19;NSD1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.43937140046812506,1.3595739750099622,0.001,0.671331113168172,1.0,178/731,18.68%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;FOXN2;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,mRNA 3'-UTR binding (GO:0003730),0.47376522470383603,1.3592172077819666,0.07692307692307693,0.6643299514743154,1.0,13/79,8.81%,RBMS3;IGF2BP1;RBMS1;ZFP36L1;IGF2BP2;ZFP36L2;ILF3;PUM1;CPEB1;CARHSP1;PABPC4;CELF1;EXOSC4
prerank,transcription coactivator binding (GO:0001223),0.5875777367064228,1.3570806873317898,0.13132694938440492,0.6641354475985949,1.0,5/20,14.44%,RORA;AHR;TERT;SMAD3;SMAD4
prerank,carboxylic acid binding (GO:0031406),-0.3838830345761812,-1.3570620791516432,0.08040201005025126,0.5288392373700818,1.0,13/38,17.88%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLUD1;GLRA1;SESN2;SESN3;GRIN2B;PHYH;MAG;GLRA2
prerank,retinoid X receptor binding (GO:0046965),0.6539272060473839,1.3558895501387604,0.14285714285714285,0.6605887687578119,1.0,4/11,5.97%,NRIP1;TACC1;ARID5A;PPARG
prerank,DNA secondary structure binding (GO:0000217),0.5386352139761652,1.3545387101173851,0.1172680412371134,0.6571616254223794,1.0,5/31,11.00%,RAD51B;KMT2A;XRCC3;HMGB2;LIN54
prerank,acylglycerol lipase activity (GO:0047372),-0.5507068041421784,-1.3516197992309325,0.12130177514792899,0.5312216350517684,1.0,4/11,10.71%,MGLL;ABHD6;ABHD3;LIPE
prerank,cysteine-type peptidase activity (GO:0008234),0.4741393793225207,1.3512825267630173,0.08577878103837472,0.6612903166459141,1.0,19/73,13.19%,CASP4;PDIA3;CASP1;USP9X;OTULINL;CTSS;SFRP1;CTSK;CTSL;CAPN2;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,lipoprotein particle binding (GO:0071813),0.587138797909225,1.350446014282285,0.13911845730027547,0.6567710511292357,1.0,7/20,8.76%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36;LPL
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.49208116002134866,1.348865973487507,0.08158508158508158,0.6548451648981974,1.0,11/60,7.98%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;NRP1;EGFR;EPHB3;DDR2;EPHA1;MERTK
prerank,sequence-specific DNA binding (GO:0043565),0.4367486624967657,1.3463746221850499,0.002,0.6566151460957411,1.0,108/590,14.46%,RORA;NR1H4;RUNX2;KMT2A;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;CXXC1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;EGR3;RARB;IRF7;GATA6;MAFB;SNAI2;BATF;RXRG;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;TBX2;PKNOX2;ELF4;NR2F2;ARID5A;MBD2;E2F1;PRDM5;PRDM2;BCL2;CEBPD;SMG7;TCF12;HIVEP1;FOXK2;PPARG;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;TERT;SMG6;HOXA1;POU2F1;FOXO3;ZBTB38;SMAD5;PRDM1;NR2F1;JUNB;CXXC5;TGIF2;ZIC1;TBX3;TCF7;CBFB;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;KDM2A;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;FOXJ3;NFKB2;TFCP2L1;SAFB2;CTCF;SMAD3;LRWD1;IRF9;CTC1;EGR2;HOXB5;TFAP2C;SMAD4;MAFK
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5800296226544486,1.3443290842168545,0.1389290882778582,0.6564702200655251,1.0,1/20,0.13%,SLC39A14
prerank,lipase activator activity (GO:0060229),0.6693571241588401,1.3440996533364733,0.14630225080385853,0.6498355968002845,1.0,4/10,14.06%,APOH;CCL5;ARHGAP6;SRC
prerank,ferrous iron binding (GO:0008198),0.5708942439959171,1.3440298566782074,0.1412894375857339,0.6428037405644502,1.0,5/21,12.02%,HEPH;FXN;FTO;ALKBH1;TET2
prerank,phosphotyrosine residue binding (GO:0001784),0.5168050384719006,1.3437177576894423,0.125,0.6368794863416858,1.0,14/37,18.62%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;GRB2;SHB;VAV1;PIK3R1;YES1;RASA1;PTPN5;SHD
prerank,four-way junction DNA binding (GO:0000400),0.5848476847928545,1.3344499993194079,0.13817663817663817,0.6621827554418378,1.0,3/17,10.06%,RAD51B;XRCC3;HMGB2
prerank,chloride channel regulator activity (GO:0017081),-0.49409867834113363,-1.331864506682126,0.13496932515337423,0.5721134701684375,1.0,5/14,24.45%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4984838730188769,1.330882685783678,0.11017964071856287,0.6671351068588685,1.0,14/44,16.10%,KMT2A;CXXC1;RBBP5;KMT5A;EHMT1;SETMAR;SETD2;SETDB1;KMT2E;SETDB2;KMT2B;NSD3;ASH1L;NSD1
prerank,glutamate receptor binding (GO:0035254),-0.46920836216990924,-1.3295864015161103,0.12418300653594772,0.5646737864872009,1.0,8/17,12.51%,SHANK3;SHISA6;HOMER2;NSF;SYNDIG1;SHANK1;IGSF11;HIP1
prerank,poly-purine tract binding (GO:0070717),0.5414176734006209,1.327258040179647,0.15625,0.6730351010562673,1.0,5/27,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,solute:anion antiporter activity (GO:0140323),-0.4988320777333276,-1.326162663398788,0.12571428571428572,0.5609740619375087,1.0,3/14,10.82%,SLC26A7;SLC26A2;SLC4A3
prerank,MAP-kinase scaffold activity (GO:0005078),0.6365179138997343,1.319176424269051,0.1628614916286149,0.6952435719328612,1.0,9/11,28.10%,SH3RF1;MAP2K1;AKAP13;MAPK8IP1;SPAG9;MAPK8IP3;MAPK8IP2;MAP2K2;KSR1
prerank,NAD binding (GO:0051287),-0.419354357034028,-1.3109263887769882,0.12121212121212122,0.5908634850433739,1.0,14/26,25.71%,ALDH1A1;ME1;GLUD1;ALDH2;SIRT5;NUDT6;HPGD;CTBP1;CRYZ;NNT;ZC3HAV1;CRYL1;UXS1;HADH
prerank,inward rectifier potassium channel activity (GO:0005242),-0.41291679375744494,-1.310799291313858,0.11507936507936507,0.5786656882856466,1.0,8/24,15.79%,KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10;KCNJ12;KCNN2;KCNN3
prerank,Wnt-activated receptor activity (GO:0042813),0.5936272987677179,1.3101596921552878,0.1681159420289855,0.7211333026828213,1.0,2/15,5.85%,ROR1;FZD1
prerank,bHLH transcription factor binding (GO:0043425),0.5587213877887856,1.3088424149715152,0.17275280898876405,0.7182666430448218,1.0,8/19,19.43%,FHL2;USF1;TCF12;CREBBP;BHLHE40;SMAD3;TCF3;KDM1A
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5096765026710511,1.3078962034585635,0.13784461152882205,0.7146119837562274,1.0,9/35,16.15%,TEC;PEAK1;BLK;STYK1;FRK;PTK2;SRC;FES;YES1
prerank,ephrin receptor binding (GO:0046875),0.5566497013848449,1.3054513098563019,0.1700960219478738,0.7162778804925062,1.0,6/21,8.60%,EFNA4;ANKS1B;PTPN1;CBL;GRB2;EFNA5
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6112164751957558,1.3053215563953333,0.1801526717557252,0.7096147307906286,1.0,5/12,15.16%,SULF1;GALNS;ARSG;GNS;IDS
prerank,receptor ligand activity (GO:0048018),0.4286774783941573,1.3045407411942584,0.028254288597376387,0.7052489263267676,1.0,41/245,15.01%,CCL11;EPHA7;IL34;ADIPOQ;WNT2;CXCL1;EDN3;TNFSF11;PTN;IL16;TIMP1;FGF7;WNT9A;TSLP;JAG1;MDK;SHH;CCL5;EGF;TGFB3;CXCL10;INHBB;AIMP1;GPNMB;WNT5A;IL7;BMP5;GREM2;HMGB2;SEMA3E;TGFB2;EDA;TNF;VEGFC;FGF2;BTC;INSL6;BMP7;NPY;CX3CL1;FAM3C
prerank,neuropeptide binding (GO:0042923),-0.4471601574505305,-1.303085739921274,0.14333333333333334,0.587983381986431,1.0,11/18,46.62%,SORL1;GPR37;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,carbohydrate kinase activity (GO:0019200),0.637555490971948,1.3026890282900865,0.17307692307692307,0.7053217652270773,1.0,6/11,22.77%,HK2;GALK2;GALK1;KHK;POMK;GNE
prerank,endopeptidase inhibitor activity (GO:0004866),0.4620522358885779,1.3009560900062465,0.1111111111111111,0.7045603220681886,1.0,15/82,14.45%,KNG1;SERPING1;TFPI2;FETUB;SERPINE2;TIMP1;PROS1;SERPINH1;SERPINF1;PZP;SERPINA2;GAPDH;PSMF1;SERPINB8;ITIH3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6047450172742805,1.3007096612306477,0.18769716088328076,0.6986286917323266,1.0,3/12,5.14%,CASP8AP2;CASP1;NOD1
prerank,cation:chloride symporter activity (GO:0015377),-0.5281698481357832,-1.3005047363410989,0.16761363636363635,0.582556422208889,1.0,4/10,4.88%,SLC12A2;SLC12A7;SLC12A6;SLC6A1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4193244786163259,1.2984753972796004,0.003,0.6996154151838148,1.0,189/830,18.68%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;ETV6;DEAF1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;PRDM2;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ETV5;ENO1;ZNF250;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;BBX;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;NFXL1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;ZNF25;NFE2L1;ATF4;GLI1;ETS1;ZNF3;PRDM4;SALL3;LHX6;ZSCAN29;PAX8;ZBTB40;RBPJ;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6206854597453141,1.297767518243096,0.2078125,0.695167463473065,1.0,1/10,0.09%,FAP
prerank,glucuronosyltransferase activity (GO:0015020),0.5546196085257572,1.2950495409749492,0.17541436464088397,0.6979037100671948,1.0,3/19,9.33%,EXT1;EXT2;CHSY1
prerank,poly(A) binding (GO:0008143),0.5516543478050125,1.2938879353760377,0.17828418230563003,0.6957710592771172,1.0,4/21,7.97%,RBMS3;RBMS1;KHDRBS1;PABPC4
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3761748405534079,-1.2911361946919377,0.13063063063063063,0.5967405501453824,1.0,8/31,7.17%,SLC12A2;SLC12A7;KCNK5;TMEM175;SLC12A6;KCNK10;ABCC9;KCNQ4
prerank,nuclease activity (GO:0004518),0.47471441606012027,1.2910943325160162,0.1342925659472422,0.6989531802145191,1.0,10/52,9.99%,ENPP1;ERN2;DNA2;REXO1;MAP1S;RNASE7;RNASEH1;SND1;SETMAR;RNASEH2A
prerank,thyroid hormone receptor binding (GO:0046966),0.5137029869130099,1.2876473931917518,0.16404199475065617,0.7044941752319511,1.0,11/28,19.61%,TACC1;ARID5A;TAF7;GTF2H1;OASL;MED13;HMGN3;NSD1;THRAP3;MED12;MED1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.37728045736682003,-1.2858771428988283,0.10152284263959391,0.5994378367029647,1.0,9/33,13.36%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA;LLPH
prerank,insulin-like growth factor I binding (GO:0031994),-0.4862886528627631,-1.2824872249685229,0.18155619596541786,0.5964459644407837,1.0,6/13,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.417225502651624,-1.2823324997951469,0.15498154981549817,0.5856783988519189,1.0,4/21,16.55%,GRM1;GRIA1;GRM5;CHRNB1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4826447030865625,-1.2822269984179089,0.1623931623931624,0.5752011934859121,1.0,5/13,7.25%,GABRA2;GLRA3;GABRG3;GABRA5;GLRA1
prerank,chemokine receptor activity (GO:0004950),0.5267575541947357,1.28221565638145,0.19623655913978494,0.717383483502047,1.0,3/24,9.00%,CMKLR1;CCR1;CXCR4
prerank,protein kinase inhibitor activity (GO:0004860),0.490001428595155,1.2819051736429823,0.14217443249701314,0.7120640580983583,1.0,18/42,20.44%,SPRED1;PARVA;SPRED2;NCK1;TAOK3;GSKIP;RPTOR;IBTK;GMFB;SPRY2;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.3445402132552032,-1.2818091683868036,0.07936507936507936,0.5657863655244464,1.0,29/57,28.94%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFB6;NDUFA8;CYB5A;NDUFB7;NDUFS3;COX5B;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;CYBRD1;CYB561A3;UQCR10;UQCR11;NDUFS5;NDUFV1
prerank,ADP binding (GO:0043531),-0.399241385530666,-1.2803993106306426,0.12133891213389121,0.5592591844740851,1.0,10/25,17.00%,PRKAG2;GCLC;ME1;GLUD1;MYO18A;MSH2;PPP5C;ERN1;PGK1;ATP5F1D
prerank,double-stranded DNA binding (GO:0003690),0.415656491524104,1.2799841478444367,0.005,0.7119527013387847,1.0,83/531,13.00%,RUNX2;RAD51B;ZBP1;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;RBMS1;GLI2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;STAT1;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;SMAD2;NFIX;EGFR;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;CGGBP1;TBX2;PKNOX2;ELF4;E2F1;CEBPD;TCF12;HIVEP1;PPARG;ZBTB48;DDX11;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;HOXA1;FOXO3;SMAD5;SETMAR;PRDM1;NR2F1;JUNB;FBH1;HMGB2;TGIF2;ZIC1;TBX3;TCF7;TEAD1;FOXN2;KLF10;BBX;ELK4;SAFB;SP3;E2F3;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.37730538660840385,-1.2778871354971262,0.12389380530973451,0.5558169550427969,1.0,10/32,24.06%,KCNC2;KCNB2;KCNQ5;KCNQ3;KCNQ4;KCNQ1;KCNC1;KCNQ2;KCNC3;KCNE4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.41320675754681335,1.2760984952440075,0.004,0.7191533301015411,1.0,137/597,18.89%,RUNX1;RUNX2;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;GLI2;YAP1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;GLI3;BCL6;CREB3L3;MEIS2;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;ARID5B;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;TBX2;PKNOX2;RBBP5;ELF4;ARID5A;MBD2;E2F1;PRDM5;CEBPD;MCM2;TAF7;TCF12;HIVEP1;FOXK2;PPARG;ZBTB48;DDX11;ETV5;ZNF250;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;IRF1;BHLHE40;CARM1;CREB3L2;HOXA1;MCM7;AHRR;NONO;FOXO3;TBL1X;SMAD5;PRDM1;NR2F1;GRWD1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;MCM9;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;SP3;ARID4B;E2F3;TNF;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;IRF9;EGR2;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;BNC2;CREB3L4;CREB3;NR6A1;NPAS2;MAX;CLOCK;TCF7L1;SREBF1;HSPD1;BACH2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PRDM4;LHX6;ZSCAN29;PAX8;HDAC5;NR2C2;SOX2;HINFP;ZBTB7A;ARID4A;NR3C1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6236952579869081,1.2758349572065324,0.22274881516587677,0.7138097298633862,1.0,6/10,18.48%,SETMAR;SETD2;NSD3;ASH1L;NSD1;SETD3
prerank,exopeptidase activity (GO:0008238),0.47219651479250596,1.2749757649947324,0.14858490566037735,0.7103623865726777,1.0,15/50,18.97%,FAP;XPNPEP2;ANPEP;DPEP2;XPNPEP1;NPEPPS;ENPEP;DPP7;XPNPEP3;DPP8;CNDP2;GGH;CTSA;LAP3;DPEP3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5359598833111807,-1.274171124199724,0.18814432989690721,0.5558049106936817,1.0,8/10,30.09%,DNAJC2;ANKRD13A;IDE;FAAP20;USP15;FAN1;DNAJB2;ANKRD13D
prerank,metalloexopeptidase activity (GO:0008235),0.46498042927922,1.2722243202501011,0.15348288075560804,0.7135245037668231,1.0,13/51,14.50%,MMP14;ANPEP;CPQ;XPNPEP1;CPXM1;NPEPPS;CPA6;MMP16;ENPEP;AGTPBP1;MMP15;LVRN;XPNPEP3
prerank,pseudouridine synthase activity (GO:0009982),0.5953360676832145,1.271895726922457,0.19435736677115986,0.7088597747586812,1.0,4/13,9.72%,RPUSD3;PUS7L;TRUB2;PUS3
prerank,potassium ion leak channel activity (GO:0022841),-0.45421288027908596,-1.2718219737202834,0.16761363636363635,0.552339416420973,1.0,7/15,25.91%,KCNK5;TMEM175;KCNK10;KCNK2;KCNK13;KCNK6;KCNK12
prerank,vinculin binding (GO:0017166),-0.5112682185554822,-1.2687544635200616,0.20689655172413793,0.5504338394793926,1.0,3/11,4.72%,DMD;RTCB;SORBS3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5397955283230118,-1.2677932829166945,0.20408163265306123,0.5437910034675381,1.0,4/10,7.90%,PRKAG2;PRKAR1A;PRKAR2A;PKIA
prerank,chemorepellent activity (GO:0045499),-0.3918285286895312,-1.2642073047371416,0.15040650406504066,0.543501470945112,1.0,7/25,3.17%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;NRG3;SEMA7A;DPP4
prerank,nuclear receptor coactivator activity (GO:0030374),0.46088261898174543,1.258385601644643,0.1629013079667063,0.7482474599532586,1.0,22/52,22.53%,CCAR1;ZMIZ1;TACC1;PPRC1;CARM1;CCAR2;PSMC3IP;MED13;FGF2;ELK1;USP22;SLC30A9;CALCOCO1;THRAP3;ETS1;KDM1A;MED12;MED1;TMF1;ACTN1;PKN1;MED14
prerank,hormone receptor binding (GO:0051427),0.5775320697642059,1.256672633763217,0.22054380664652568,0.7481317353856298,1.0,2/14,2.75%,JAK1;JAK2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5877166518238324,1.2548768620267317,0.23113207547169812,0.7483996767168161,1.0,3/12,9.16%,STAT1;POU2F1;HDAC1
prerank,diacylglycerol kinase activity (GO:0004143),-0.5098839226381487,-1.2546282838338003,0.19174041297935104,0.5581484643825992,1.0,5/11,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,calcium ion binding (GO:0005509),0.40991237002057246,1.2537409394626555,0.04632426988922457,0.7463683006737961,1.0,63/323,15.97%,MMP13;SCUBE1;ENPP1;LRP1;FBLN1;SPARC;CDH11;THBS4;PCDHB6;MASP1;CRP;SLIT3;SLIT1;PAM;CALR3;ADGRL3;CALML4;ITSN1;GALNT3;CALU;PADI2;SHH;FBN1;ITPR1;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;CDH6;CANX;SYT2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDH18;CDH24;RCN3;CALR;MICU2;AIF1L;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E
prerank,insulin-like growth factor binding (GO:0005520),-0.46215466849961157,-1.2527892022029208,0.16025641025641027,0.5536727620055845,1.0,6/15,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,neuropeptide hormone activity (GO:0005184),0.5325493772905406,1.2521189955232275,0.20684931506849316,0.7457954960646226,1.0,3/22,14.33%,QRFP;HCRT;NPY
prerank,kinase inhibitor activity (GO:0019210),0.49522465465634724,1.2506952565779752,0.19576059850374064,0.7446237390002134,1.0,14/33,20.44%,PARVA;NCK1;LRP6;TAOK3;GSKIP;GMFB;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,pentosyltransferase activity (GO:0016763),0.48163148993294314,1.248026325327727,0.18696186961869618,0.74787500772702,1.0,4/36,6.77%,PARP8;PARP3;LACC1;PARP11
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.47981396776258706,1.239048347056833,0.1935483870967742,0.7723302287884719,1.0,17/35,26.44%,STAT1;SNAPC3;POU2F1;HDAC1;KLF10;DRAP1;TAF4;BAZ2A;SMARCA4;NR3C1;AGO2;FOXP1;AGO1;RRN3;RELA;FOS;PIH1D1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6139803260741912,1.238971014071635,0.2459807073954984,0.7664938410176011,1.0,3/10,3.91%,CACNA1A;CACNA1C;CACNB1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3641308145960756,-1.2377262211819626,0.1487603305785124,0.581730192316568,1.0,4/29,3.71%,SLC13A3;SLC26A7;SLC26A2;SLC1A1
prerank,nucleotidyltransferase activity (GO:0016779),0.5297589061801781,1.2364777974226366,0.22331460674157302,0.7689677812248872,1.0,7/19,20.33%,PAPSS2;TERT;REV1;CGAS;CRPPA;TUT7;TENT4A
prerank,phosphatase binding (GO:0019902),0.4276640567971658,1.2360824385139904,0.147470398277718,0.7641906419919563,1.0,36/105,20.51%,JAK1;SPRED1;AP3B1;SMAD2;EGFR;STAT3;IKBKE;STX17;CDC27;CARHSP1;DLG4;MAST2;PDLIM4;MVP;PTK2;RCAN3;CTSC;TRAF2;PPME1;PIK3R1;GTF2F1;SMAD3;CDKN1B;VRK3;MTMR9;CEP192;ITGA1;SH3YL1;MAPK1;MTMR3;EIF2AK3;TRPC4AP;HSP90B1;SPTBN4;KIFAP3;DLG1
prerank,mannose binding (GO:0005537),0.5710428330353935,1.235492686167877,0.23765432098765432,0.7603571785203114,1.0,3/12,13.95%,LMAN2L;LMAN1;COLEC11
prerank,signal sequence binding (GO:0005048),0.4759292828100321,1.233134719188841,0.19570707070707072,0.7625118736572092,1.0,14/35,19.93%,CEMIP;KDELR3;BABAM2;KPNA3;BRAP;NUP153;TNPO1;KDELR2;SEC61A1;SEC61A2;KCNIP2;NFKBIA;NUP214;KPNA2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3603482383461563,-1.2330037576550013,0.1588785046728972,0.5846274567803852,1.0,8/33,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.409439147720637,1.2329422670465011,0.11065573770491803,0.7573565911947564,1.0,47/181,18.77%,NR1H4;MDFIC;NCOR2;TCF7L2;NRIP1;PRRX1;STAT1;RERE;ZFPM2;MIER2;TACC1;STAT3;TEAD3;CREBBP;PPARG;PIAS2;ARNT;BHLHE40;PSMA6;HDAC1;MTA2;TBX3;NFE2L2;GSK3B;DUSP26;ELK1;COMMD7;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TAF4;DTX3L;BAZ2A;HIF1A;TCF3;SMARCA4;MTA3;TCERG1;ATF4;RBPJ;HDAC5;NFKBIA;SPEN;RBBP8;BCAS3
prerank,iron ion binding (GO:0005506),0.45188624781443504,1.231769941431891,0.20722891566265061,0.7555251096772034,1.0,10/48,12.52%,HEPH;FXN;PHF2;ABCE1;ACO2;SCD5;FTO;ALKBH1;TET2;CYP2R1
prerank,leucine zipper domain binding (GO:0043522),0.5969791818721774,1.2311315359527424,0.25380710659898476,0.7517511502879987,1.0,4/10,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40412915747832123,1.2285995867691535,0.08980827447023208,0.7543666247690479,1.0,59/254,18.89%,RUNX1;NR1H4;CREB3L1;TCF4;PRRX1;CREB3L3;SATB2;MEIS2;NPAS4;MITF;SMAD2;REL;UBP1;STAT3;LITAF;MEIS1;HOXB3;ELF4;MYBL1;PRDM2;TCF12;FOXK2;ETV5;MLXIP;IRF1;HOXA1;FOXO3;KLF10;ELK4;E2F3;ZSCAN21;HOXB2;KLF6;NKX2-8;ELK1;FOXJ3;NFKB2;TFCP2L1;SMAD3;EGR2;ZFP62;TFAP2C;SMAD4;SMAD1;CREB3;HIF1A;CLOCK;TCF3;ZNF445;MZF1;MDM2;ATF4;ETS1;RLF;PRDM4;RBPJ;NR2C2;HINFP;NR3C1
prerank,cholesterol binding (GO:0015485),0.46111841227108985,1.227107241100727,0.2061248527679623,0.7536580620997858,1.0,10/47,11.03%,ABCA1;APOD;ABCG1;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,metal ion binding (GO:0046872),0.39701595415143265,1.2255930569555078,0.036,0.7533933461447698,1.0,92/477,16.28%,MMP13;SCUBE1;ENPP1;POSTN;NEK6;LRP1;FBLN1;SPARC;CDH11;PDXP;THBS4;PCDHB6;MASP1;CRP;ERN2;LRRK2;SLIT3;SLIT1;PAM;CALR3;PPA1;ADGRL3;MARK1;IRAK3;APOE;CALML4;ITSN1;GALNT3;CALU;PADI2;ADCY2;SHH;FBN1;ITPR1;EPHX2;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;MVK;FOXK2;RAP2A;PLK1;CDH6;HSPE1;CANX;MAST2;SYT2;RRAGC;IDH2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDC42BPA;GNAI1;CDH18;CDH24;RCN3;CALR;TDP2;MICU2;ACVR1C;PAPOLG;ADPRH;AIF1L;MAP3K6;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;DXO;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E;STK4;MCTP2
prerank,zinc ion binding (GO:0008270),0.39907730254270835,1.2238476412660397,0.08542713567839195,0.7539453715375113,1.0,48/293,14.00%,MMP13;ENPP1;KMT2A;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;ANPEP;LITAF;SHH;PHF2;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;TRIM8;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;UBA5;EEA1;CALR;TET2;KDM2A;KMT2B;LVRN;CTCF;SMAD3;RNF11
prerank,copper ion binding (GO:0005507),0.4701135655566512,1.2220467214269395,0.21614906832298136,0.7545301460506812,1.0,3/42,2.51%,HEPH;LACC1;PAM
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5980947666037255,1.218160565566471,0.2590759075907591,0.7620825201564831,1.0,2/11,4.84%,RASA3;ITPR1
prerank,leak channel activity (GO:0022840),-0.4176416553677362,-1.2163203832172707,0.19032258064516128,0.6167166314548088,1.0,7/18,21.31%,KCNK5;TMEM175;KCNK10;KCNK2;NALCN;KCNK13;KCNK6
prerank,neuropeptide receptor activity (GO:0008188),-0.36630322696328155,-1.2141101744764458,0.203125,0.6127623771851474,1.0,19/29,48.24%,SORCS1;SORCS3;SORCS2;GPR37;NPSR1;HCRTR2;OPRM1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,DNA-binding transcription factor binding (GO:0140297),0.4023490386068389,1.21298456175545,0.12512820512820513,0.7740406767861033,1.0,53/189,19.43%,NEK6;YAP1;TCF7L2;PRRX1;STAT1;RERE;ZFPM2;FHL2;SMAD2;MIER2;TLE1;USF1;STAT3;CGGBP1;TEAD3;PRDM5;BCL2;TCF12;CREBBP;PPARG;RUNX1T1;PIAS2;NOC2L;BHLHE40;CRTC1;HDAC1;MTA2;CXXC5;TBX3;YWHAZ;CRTC3;NFE2L2;GSK3B;DUSP26;ELK1;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TCF3;MTA3;TCERG1;ATF4;RBPJ;DDX20;HDAC5;SPEN;RBBP8;ZBTB7A;TLE5;GABPA;KDM1A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.43088575588605704,1.2123687725773602,0.21380846325167038,0.770627769211548,1.0,13/70,16.66%,CHSY3;B4GALNT2;EXT1;EXT2;GXYLT2;B4GALNT1;OGT;MGAT4A;CHSY1;GCNT2;POGLUT3;CHPF2;B3GNT9
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.565376411298154,1.210797903336968,0.2659732540861813,0.7702093449605348,1.0,5/13,13.51%,PDGFRA;IL1R1;PDGFRB;PTPRJ;ITGA5
prerank,heme binding (GO:0020037),0.43764716655543756,1.2092123744894707,0.20649651972157773,0.7699538482275934,1.0,12/65,15.31%,CYP1B1;STEAP4;BACH1;JAK2;CYP2A6;PTGES2;PXDN;HEBP1;CYP2R1;TBXAS1;SRC;CYCS
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.47499350033828697,1.2077906785901518,0.2131782945736434,0.7693052929553026,1.0,11/34,16.20%,TAOK1;RICTOR;FAM20A;CKS1B;MAP2K1;DBF4;SPRY2;CALM2;CCNT1;ALS2;STK4
prerank,peptidase inhibitor activity (GO:0030414),0.47647658064844767,1.2074888166245237,0.24744897959183673,0.765088541062442,1.0,5/33,7.34%,KNG1;FETUB;TIMP1;PROS1;PZP
prerank,histone acetyltransferase binding (GO:0035035),0.5114196295618955,1.2073591817457063,0.24005681818181818,0.7602814569606047,1.0,8/21,18.77%,GLI3;STAT1;TAF7;KANSL1;EID1;HIF1A;ZBTB7A;BCAS3
prerank,phospholipase activator activity (GO:0016004),0.5869906867409136,1.2070366050910586,0.27936507936507937,0.7562017687774936,1.0,3/10,14.06%,CCL5;ARHGAP6;SRC
prerank,sodium channel regulator activity (GO:0017080),-0.34532656798007444,-1.2061982674130634,0.17105263157894737,0.6240117208899127,1.0,8/37,10.52%,FGF12;FGF14;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6;GPLD1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.49860811079787726,1.2061647995347622,0.240473061760841,0.7540116197783496,1.0,3/25,6.77%,PARP8;PARP3;PARP11
prerank,glycerophospholipid flippase activity (GO:0140333),-0.4823607482795932,-1.205483781225077,0.24,0.6167703189181705,1.0,5/11,9.89%,ATP10A;ATP8A1;ABCA4;ABCA3;ATP8A2
prerank,transcription coregulator binding (GO:0001221),0.445799201488588,1.2054271238386136,0.2294887039239001,0.7512473470565205,1.0,10/50,14.44%,RORA;NEK6;PHF1;EHMT1;AHR;TERT;LCOR;CTCF;SMAD3;SMAD4
prerank,transition metal ion binding (GO:0046914),0.39082634260680166,1.2050300308771573,0.069,0.7472273815289224,1.0,69/397,15.81%,MMP13;HEPH;ENPP1;KMT2A;MGAT5;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;LACC1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;SLC11A2;ANPEP;LITAF;GALNT3;ADCY2;SHH;PHF2;XPNPEP1;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;ABCE1;ACO2;NEK4;TRIM8;SCD5;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;LOXL3;UBA5;EEA1;CALR;TDP2;TET2;KDM2A;CYP2R1;KMT2B;LVRN;CTCF;SMAD3;RNF11;XPNPEP3;SIRT3;RABGGTB;SMPDL3B;B4GALT7;FNTB;FBXL19
prerank,potassium channel activity (GO:0005267),-0.27778141966944725,-1.2026255443949614,0.1038961038961039,0.6154731151481743,1.0,22/89,16.07%,KCNC2;KCND3;GRIK4;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNK10;ABCC9;KCNQ3;KCNQ4;KCNK2;KCNQ1;LRRC38;CCDC51;KCNN2;GRIK2;KCNC1;KCNT1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.448395960345004,-1.195526787633052,0.26851851851851855,0.625614253370461,1.0,2/14,1.78%,SLC26A7;SLC26A2
prerank,ATPase binding (GO:0051117),0.4256390400109852,1.1930701800376846,0.2341628959276018,0.7803231643040964,1.0,19/71,16.67%,ABCA1;NKD2;SLC2A13;DNAJB1;EGFR;CHMP4A;BBC3;PTPN3;PKD2;RALA;PPP3CA;VCPKMT;PEX19;SNX10;PSEN1;SRC;TMTC4;TOR1AIP2;ATP6V1G1
prerank,lysine N-methyltransferase activity (GO:0016278),0.5079404546711478,1.1915259828863818,0.2677595628415301,0.7803123412930729,1.0,12/20,27.82%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.56886414628098,1.191086417644737,0.29448818897637796,0.7768002149917833,1.0,1/11,4.11%,PADI2
prerank,sulfotransferase activity (GO:0008146),-0.3384074657164101,-1.1910654853878442,0.1625615763546798,0.6275042027804419,1.0,11/33,13.49%,HS3ST3A1;HS3ST1;UST;SULT1A1;CHST8;CHST9;GAL3ST1;TPST2;CHST3;HS6ST1;HS3ST2
prerank,MAP kinase phosphatase activity (GO:0033549),0.5697650932313734,1.189621826731747,0.28110599078341014,0.7764777551561656,1.0,2/12,3.00%,DUSP2;DUSP5
prerank,muscle alpha-actinin binding (GO:0051371),0.5479483621248642,1.185788716747823,0.27835051546391754,0.7840454475569144,1.0,3/15,8.37%,PALLD;PKD2;PDLIM4
prerank,NAD+ binding (GO:0070403),-0.46871035527799004,-1.1853206930796978,0.2740963855421687,0.6325399567657379,1.0,7/12,25.71%,GLUD1;SIRT5;HPGD;ZC3HAV1;CRYL1;UXS1;HADH
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5913748119017984,1.184893050328659,0.2976,0.7770264745305688,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5913748119017984,1.184893050328659,0.2976,0.7770264745305688,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.43673011643453136,1.1834342711193881,0.2505827505827506,0.7764083295524392,1.0,4/53,3.47%,SLC7A2;SLC1A3;SLC38A3;SLC7A7
prerank,solute:proton symporter activity (GO:0015295),0.5239178465931179,1.182606049752426,0.27906976744186046,0.7744310015763121,1.0,4/16,10.09%,SLC2A13;SLC11A2;SLC36A2;SLC15A1
prerank,amino acid binding (GO:0016597),-0.3470224874880975,-1.182246430762519,0.19626168224299065,0.6315232842571653,1.0,7/31,11.07%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLRA1;GRIN2B
prerank,R-SMAD binding (GO:0070412),0.5243320985971356,1.179579827010677,0.2650957290132548,0.779176651000174,1.0,7/18,17.23%,PMEPA1;SMAD2;LDLRAD4;SMAD3;SMAD4;SMURF1;TRIM33
prerank,MAP kinase activity (GO:0004707),-0.44584628272097104,-1.179414374407947,0.23397435897435898,0.6308877889732871,1.0,8/14,24.48%,MAPK4;MAPK12;MAPK9;MAPK10;MAPK3;MAPK6;MAPK14;MAPK7
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.540478880215145,1.1784111298176143,0.3078034682080925,0.7779631308587028,1.0,3/14,8.05%,CAPN5;CAPN2;CAPN15
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.39056435276030005,-1.1779181029372063,0.20300751879699247,0.6264968301186975,1.0,5/20,14.31%,LPGAT1;LPCAT2;AGPAT3;DGAT1;GPAT4
prerank,DNA binding (GO:0003677),0.3799863077605991,1.172274504879822,0.052,0.7923276665992883,1.0,159/694,18.79%,RORA;NR1H4;RAD51B;ZBP1;ZEB2;POU5F1;RBMS1;C1D;GLI2;MPG;TCF7L2;TCF4;BCL6;MEIS2;STAT1;RARB;IRF7;BRIP1;MAFB;SNAI2;SMC1A;DNA2;BATF;RAD52;ZNF496;ARID5B;SMAD2;EGFR;ZIC4;USF1;STAT3;CGGBP1;MEIS1;TBX2;SOX21;ILF3;NR2F2;ARID5A;MAP1S;E2F1;PRDM5;PHF1;KHDRBS1;PRDM2;BCL2;MCM2;HIVEP2;INO80;FOXK2;CREBBP;PPARG;YAF2;ZNF292;DDX11;ETV5;MBD1;AHR;PDS5B;TSHZ3;FOXE1;SUB1;ARNT;IRF1;FUBP1;DCLRE1C;AIFM2;SNAPC3;TERT;HOXA1;POU2F1;MCM7;RAD23A;FOXO3;RAD23B;SETMAR;NR2F1;OASL;JUNB;FBH1;HMGB2;CXXC5;TBX3;MCM9;CBFB;ZMYM4;TEAD1;CHD2;XRN1;ELK4;NFE2L2;ZGPAT;SAFB;CALR;TIMELESS;TDP2;SPTY2D1;E2F3;HOXB2;GLYR1;NKX2-8;FOXJ3;SAFB2;CTCF;SMAD3;RBM6;COLEC11;RNF11;CTC1;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;SIRT3;SETX;PATZ1;POLG;NR6A1;CCNT1;HIF1A;GTF3C4;PRKDC;NPAS2;NUP35;CGAS;POU3F3;MAX;LIN9;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;HMGN1;PNKP;AIFM1;POLRMT;HSPD1;NUCKS1;RC3H2;CALCOCO1;THRAP3;DDB1;ATF4;GLI1;ETS1;ZNF3;RLF;PAX8;RBPJ;NR2C2;SOX2;RBBP8;CDK9;HINFP;ZBTB7A;HMCES;ARID4A
prerank,endopeptidase regulator activity (GO:0061135),0.45375906353162093,1.1716129368909711,0.2691358024691358,0.7895599857973606,1.0,10/40,17.78%,KNG1;FETUB;PROS1;ABCA2;PZP;PSMF1;ITIH3;PSENEN;PSMD14;PCSK1N
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3695418096148731,-1.1702611940385859,0.25213675213675213,0.6384792304970456,1.0,8/27,9.76%,SLC12A2;ITPR2;TMEM165;MRS2;ATP2B4;SLC9B2;ZDHHC13;SLC4A8
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5343123275181231,1.169634899087195,0.3008982035928144,0.7911336896191937,1.0,3/14,12.47%,TSEN2;POP1;POP4
prerank,WW domain binding (GO:0050699),0.4801912914393422,1.1695761593173617,0.2803129074315515,0.7865779431008327,1.0,3/26,8.17%,PMEPA1;LITAF;PRRG4
prerank,regulatory RNA binding (GO:0061980),0.45046457834035053,1.169519494818648,0.27249683143219267,0.7820767564210146,1.0,14/38,24.18%,POU5F1;PUM1;TLR7;DICER1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,protein phosphatase regulator activity (GO:0019888),0.43203907474277103,1.1692694249176683,0.25443786982248523,0.7782407857128139,1.0,14/53,13.64%,MGAT5;PPP1R9B;PTN;RCAN2;EIF2AK2;PPP4R1;PPP2R2A;PPP2R5A;RCAN3;PPP4R2;PPP1R2;PPP1R16A;PPME1;CALM2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4843637353036112,1.167965403107504,0.29110512129380056,0.7776297197460196,1.0,4/26,9.33%,CHSY3;B4GALNT2;B4GALNT1;CHSY1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.46705399632445244,1.1674319986819173,0.2857142857142857,0.7748243693842747,1.0,7/30,18.03%,SLC39A14;SLC11A2;SLC25A37;SLC31A1;SLC39A6;TTYH1;ATP7A
prerank,O-methyltransferase activity (GO:0008171),0.5785208837925448,1.1646956276559357,0.3236196319018405,0.7785845509489865,1.0,5/10,24.63%,ASMT;COMT;BCDIN3D;FTSJ3;COQ3
prerank,gated channel activity (GO:0022836),0.5290974526818278,1.1640229611117558,0.31490015360983103,0.7758610775275262,1.0,3/14,6.89%,TMC3;PIEZO2;TMEM266
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5162081324984187,1.1633108997143735,0.31555555555555553,0.77381208459452,1.0,4/17,4.34%,ABCA1;ATP8B1;PLTP;ABCG1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.45460342150469063,1.1599703421336733,0.28426395939086296,0.7797995628815994,1.0,19/34,27.82%,ANTKMT;KMT5A;EHMT1;SETD2;SETDB1;CAMKMT;KMT2E;VCPKMT;NSD3;ETFBKMT;SETD3;N6AMT1;EEF2KMT;DOT1L;SETD7;KMT5B;SETD4;METTL21A;EEF1AKMT3
prerank,Notch binding (GO:0005112),0.4779967013832819,1.1589980385834293,0.3058659217877095,0.7784086754563359,1.0,5/22,11.76%,NCOR2;JAG1;GALNT11;SNED1;KCTD10
prerank,RNA polymerase II complex binding (GO:0000993),-0.3444761022867168,-1.1577807733147114,0.22274881516587677,0.6618696372538767,1.0,8/32,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,hydro-lyase activity (GO:0016836),0.43209835565348864,1.1550346251455978,0.2848335388409371,0.7861766776062535,1.0,14/41,20.43%,EHHADH;PCBD1;GMDS;ENO1;HACD2;ACO1;ACO2;IREB2;TBXAS1;ECHS1;FAHD2A;PCBD2;AUH;ECHDC2
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.25906191874562234,-1.153808229992933,0.17391304347826086,0.6637705092998568,1.0,30/134,12.26%,ABCC4;ABCG2;SLC6A6;SLC13A3;SLC26A7;SLC26A2;SLCO1C1;SLC6A9;SLC38A9;SLC7A5;SLC1A2;SLC1A1;MPC1;SLC22A6;SLCO3A1;SLC6A1;SLC16A11;SLC39A8;SLC52A1;SLC5A6;SLC16A1;SLC25A42;SLCO2A1;SLC4A8;SLC27A1;SLC4A3;SLC38A5;SLC25A12;SLC25A38;MPC2
prerank,cAMP binding (GO:0030552),-0.46053680518975004,-1.1528113275826721,0.3150684931506849,0.6581060433828083,1.0,5/11,11.42%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A
prerank,double-stranded RNA binding (GO:0003725),0.4077100689258408,1.149204089220917,0.27200902934537247,0.7993746090651827,1.0,11/70,9.83%,ZBP1;CLTC;RFTN1;ILF3;ZFR;EIF4A1;EIF2AK2;TLR7;MSN;DICER1;OASL
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2795684442101912,-1.1481014956613163,0.14285714285714285,0.6616060503384376,1.0,21/80,16.07%,KCNC2;KCND3;KCNB2;KCND2;KCNQ5;KCNH5;KCNH7;KCNJ2;KCNJ3;KCNJ13;KCNQ3;KCNQ4;KCNJ10;KCNK2;KCNQ1;LRRC38;KCNJ12;KCNN2;KCNN3;KCNC1;KCNT1
prerank,alpha-tubulin binding (GO:0043014),0.4581974377538725,1.147692418219294,0.2833333333333333,0.7996237028156913,1.0,5/31,9.84%,DLEC1;TAOK1;EML4;INO80;SETD2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3996802345946293,1.1467372894551566,0.2677165354330709,0.7980320186981793,1.0,8/73,12.75%,MC5R;EDNRA;RXFP2;ADCYAP1R1;GLP2R;S1PR2;CALCRL;MC1R
prerank,beta-tubulin binding (GO:0048487),0.4434527739430279,1.1451121961653896,0.29473684210526313,0.7986524077393831,1.0,4/31,4.52%,DLEC1;TAOK1;EML4;MAP1S
prerank,glutathione transferase activity (GO:0004364),0.4732400635829275,1.1439337094885391,0.31077348066298344,0.7978388763529969,1.0,3/23,10.94%,PTGES;MGST1;GSTK1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5224771445578172,1.1432335286417923,0.31402439024390244,0.7955062879260814,1.0,1/14,0.63%,SLC1A3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5020687743572791,1.142163006389617,0.32152974504249293,0.7901794113220326,1.0,4/17,6.61%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,ephrin receptor activity (GO:0005003),0.5020687743572791,1.142163006389617,0.32152974504249293,0.7901794113220326,1.0,4/17,6.61%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,syntaxin-1 binding (GO:0017075),-0.37584300096737105,-1.1406154976570566,0.2681992337164751,0.6722601858025169,1.0,5/22,9.64%,UNC13C;SNAP25;UNC13B;NSF;CPLX1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.47725680329018705,-1.1405401311338872,0.2857142857142857,0.664382567191274,1.0,4/10,8.27%,SLCO1C1;SLC22A6;SLCO3A1;SLCO2A1
prerank,Tat protein binding (GO:0030957),0.5561278469972174,1.139881401156234,0.32222222222222224,0.7928637421497656,1.0,1/10,0.69%,MDFIC
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4973775535527129,1.138174363217372,0.327683615819209,0.793785864173282,1.0,6/18,13.74%,SMAD2;TGFB3;TGFBR1;TGFB2;TGFBRAP1;SMAD3
prerank,semaphorin receptor activity (GO:0017154),0.5341445230707742,1.1372502691062027,0.32310177705977383,0.7922380391517765,1.0,4/11,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5398083401611166,1.1362588343760394,0.3153846153846154,0.791002526571084,1.0,2/11,5.18%,AKR1A1;RDH12
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5195669109496379,1.1359243319282177,0.3058823529411765,0.7878747441089038,1.0,3/15,12.90%,P2RX5;P2RY14;P2RX7
prerank,outward rectifier potassium channel activity (GO:0015271),0.5461610405123324,1.1359151041515638,0.3411949685534591,0.7837429196097123,1.0,3/11,5.01%,KCNT2;KCNA5;PKD2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.428191196892389,1.1355835151469431,0.3054187192118227,0.7806661548763402,1.0,9/42,15.58%,CDKN2B;CCNE2;CCNL1;CCND3;CKS1B;CCNB2;CCNI;CDKN1B;CCNT1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5092077455305297,1.1354672280007938,0.32335329341317365,0.7769095075827821,1.0,3/14,5.14%,CASP8AP2;CASP1;NOD1
prerank,tau-protein kinase activity (GO:0050321),0.47635410280932916,1.1353703305677643,0.31759656652360513,0.7732308647760316,1.0,9/20,22.93%,TAOK1;MARK1;GSK3B;SIK3;PHKG2;DYRK1A;MARK2;ROCK2;ROCK1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5230520970003522,1.1351418505276185,0.3282442748091603,0.7698914202358063,1.0,1/13,0.79%,EHHADH
prerank,methylation-dependent protein binding (GO:0140034),0.4159158406501522,1.1347707479488018,0.28735632183908044,0.7670889978332643,1.0,21/57,24.40%,CXXC1;RBBP5;PHF1;PHF2;MORC3;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,nucleotide diphosphatase activity (GO:0004551),0.5096627812632784,1.1340364505777452,0.3312788906009245,0.7652001518911329,1.0,1/14,0.33%,ENPP1
prerank,protein kinase binding (GO:0019901),0.36444208590606225,1.1323001920530644,0.14414414414414414,0.7664074048854849,1.0,124/480,18.91%,ROR2;TRIML2;CLTC;NEK6;FAM83A;TCF7L2;RND3;GHR;TNIP1;PTN;JTB;DUSP2;IRS1;PDGFRB;GATA6;JAK2;DUSP5;SLC12A4;SPRED1;NELL1;PRKCSH;SUFU;CDKN2B;IRAK3;TREM2;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KHDRBS1;KIF13B;KCNA5;PRKD2;ACVR1;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;RPTOR;TIRAP;NEK9;MAPKAP1;BORA;NISCH;MSN;PRKAR1B;GRB2;FOXO3;TPX2;IRAK4;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;TOP2B;YWHAZ;FBXO7;NBR1;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;PJA2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;DACT1;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;TRIB1;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;TCF3;PLEK;ACVRL1;PTPRC;DUSP6;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;HDAC5;CENPJ;FBXO5;SHC2;TBL2;NR3C1;PARN
prerank,ligand-gated cation channel activity (GO:0099094),-0.28275482665649204,-1.1306573971430323,0.19387755102040816,0.6827859661887555,1.0,16/75,16.55%,GRIK4;KCNJ2;KCNJ3;GRIN3A;GRIA2;KCNJ13;GRIA1;KCNJ10;GRIN2D;GRIN2B;KCNJ12;CCDC51;KCNN2;GRIK2;KCNN3;CHRNB1
prerank,kinase binding (GO:0019900),0.36310331754927766,1.1295976343198932,0.159,0.7702496311323659,1.0,115/435,18.91%,TRIML2;CLTC;NEK6;FAM83A;TCF7L2;SNAI1;RND3;GHR;PTN;JTB;PDGFRB;GATA6;JAK2;SLC12A4;SPRED1;CASP1;SUFU;CDKN2B;EGFR;IRAK3;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KIF13B;KCNA5;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;DLG4;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;ABI2;RPTOR;NEK9;MAPKAP1;BORA;NISCH;MSN;BTG1;GRB2;RAD23A;TTC28;SP100;FOXO3;CDC37;TPX2;IRAK4;PPP2R5A;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;YWHAZ;FBXO7;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;SRC;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;ACVRL1;PTPRC;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;CENPJ;FBXO5;PIP5K1A;SHC2;TBL2;NR3C1;PARN
prerank,protein phosphatase binding (GO:0019903),0.38566832022204245,1.1235460140539433,0.2771855010660981,0.7836507442945083,1.0,32/117,18.76%,PPP1R9B;JAK1;SLC9A1;AP3B1;EGFR;STAT3;IKBKE;SMG7;STRN;STX17;CDC27;DLG4;PDLIM4;MVP;PTK2;TRAF2;PPP1R16A;PPME1;PIK3R1;AKAP11;GTF2F1;CTTNBP2NL;CDKN1B;VRK3;MTMR9;ITGA1;PTPA;MTMR3;EIF2AK3;ANKLE2;MFHAS1;HSP90B1
prerank,ribosome binding (GO:0043022),0.41999960675588555,1.1214552487710725,0.31046511627906975,0.7858128824874822,1.0,17/46,21.08%,RPSA;CPEB1;SHFL;ERI1;BAG6;SRP68;SEC61A1;YTHDF3;FMR1;CPEB4;SEC61A2;NAA15;MAIP1;SRP72;MRPS27;ETF1;ZC3H12A
prerank,carboxylic ester hydrolase activity (GO:0052689),0.387900018790111,1.1169964172840547,0.30335861321776814,0.7947399830912816,1.0,14/85,16.48%,CEL;LIPC;ASPG;PLA2G7;LPL;PLA2G12A;H6PD;ABHD16A;LYPLAL1;ABHD8;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,cAMP response element binding (GO:0035497),0.5497900959798636,1.1142728929281953,0.3682539682539683,0.7984592016412495,1.0,2/10,7.92%,CREB3L1;CREB3L2
prerank,ATP binding (GO:0005524),0.36209950277620595,1.1114869882933511,0.23564954682779457,0.8025132836225852,1.0,37/266,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,miRNA binding (GO:0035198),0.44289540187573884,1.1063955618074353,0.3548812664907652,0.8128446099339779,1.0,12/30,24.18%,POU5F1;PUM1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3864730653590984,-1.105198086155682,0.35802469135802467,0.7418192224591894,1.0,6/17,14.16%,LBR;TECR;BLVRB;BLVRA;MECR;DHCR24
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.37903553173886956,1.1046873468399483,0.31573275862068967,0.8138505134510454,1.0,24/100,17.85%,SH3PXD2B;MYO1B;MYO10;GAB2;WIPI1;CYTH3;SESTD1;DAPP1;ZFYVE26;MAPKAP1;GBF1;OGT;ANKFY1;OSBPL5;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL;ARHGAP9;AKT1;ZFYVE16
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4927234891813885,1.1032873420522544,0.3694362017804154,0.8141876786592015,1.0,1/15,0.63%,SLC1A3
prerank,methylated histone binding (GO:0035064),0.4006773964427653,1.10264325929966,0.3135011441647597,0.811957634131359,1.0,22/62,24.40%,CXXC1;RBBP5;PHF1;PHF2;MORC3;TAF7;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3004121362699365,-1.1008138491838189,0.273972602739726,0.7453808402947648,1.0,7/48,5.75%,TRPM3;SLC12A2;SLC12A7;TRPM6;TMEM165;SLC12A6;ABCC9
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3604107671953997,1.100445404389425,0.2784552845528455,0.8143401451966468,1.0,47/232,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;PIAS2;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;KCMF1;NSMCE2;FBXO2;RNF11;EGR2;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5160188359593905,1.0999573640013052,0.37770897832817335,0.811837528205471,1.0,2/12,3.43%,PDE3A;PDE7B
prerank,amyloid-beta binding (GO:0001540),0.39012740904710985,1.097497433602978,0.34551495016611294,0.8149924790340196,1.0,9/79,5.55%,CACNA1A;LRP1;HSPG2;IAPP;TLR2;TREM2;APOE;GSAP;CD36
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.42296676916262027,1.097467136006568,0.3419753086419753,0.8112193105476824,1.0,11/38,16.10%,SH3PXD2B;WIPI1;SESTD1;ZFYVE26;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL
prerank,androgen receptor binding (GO:0050681),0.4429980673245105,1.091997752575147,0.35006605019815057,0.8233697300266744,1.0,12/25,21.81%,WIPI1;ARID5A;TGFB1I1;CALR;NSD1;SMARCA4;ZBTB7A;KDM1A;TMF1;FOXP1;RNF14;PKN1
prerank,potassium channel regulator activity (GO:0015459),-0.2908703614229569,-1.0904568177183376,0.2787878787878788,0.7650045549998531,1.0,7/49,5.75%,KCNIP4;DPP10;DPP6;WNK4;WNK3;ARPP19;ABCC9
prerank,protein tyrosine kinase binding (GO:1990782),-0.26663244460551827,-1.0885330526932484,0.28448275862068967,0.7615935770391777,1.0,22/71,16.29%,EPHA4;TJP2;NEDD9;GRB14;NRG3;CDH5;GAS6;PITPNM2;HSP90AA1;DOCK4;CRK;FLT3LG;TOB1;RNF41;BLNK;FIZ1;RACK1;PIK3R2;PCNA;SHC4;MAP3K7;GRM5
prerank,ubiquitin protein ligase activity (GO:0061630),0.3554534425404768,1.0858383294471126,0.31027466937945064,0.8372471958536158,1.0,45/228,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;UBE2K;KCMF1;FBXO2;RNF11;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4387104917579737,-1.085326258142479,0.3645833333333333,0.7622142351656128,1.0,6/10,17.62%,SHANK3;SHISA6;NSF;SHANK1;IGSF11;SHISA7
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3239005805955936,-1.0848538003913286,0.29245283018867924,0.7552796525023875,1.0,8/32,11.55%,SLC6A6;SLC6A9;SLC38A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC25A38
prerank,protein homodimerization activity (GO:0042803),0.34902743959894905,1.083851213198822,0.241,0.8391980451073089,1.0,114/590,17.14%,FAP;ENPP1;KMT2A;ADIPOQ;SOHLH2;TRIML2;PDGFRA;MID1;ASMT;TBX18;GHR;MASP1;JAML;CREB3L3;STAT1;LRRK2;XCL1;ST6GAL1;EXT1;CRYM;TENM3;IRAK3;CPQ;APOE;USF1;STAT3;MTHFD1L;CHMP4A;CHMP4B;PADI2;MAD2L1;NR2F2;MYH9;ABCG1;CAMK2D;XPNPEP1;CDADC1;EPHX2;BCL2;PKD2;TRPC6;NOD1;ACVR1;PIP4K2A;EXT2;TRIM21;CCL5;LRP6;ENO1;ZHX2;GLDC;AHR;INHBB;TMEM266;IRAK2;BCL2L2;ARNT;TENM4;ACOX1;KYAT1;ADD2;BHLHE40;AIMP1;MIGA2;TRIM8;GOLGA5;TERT;PDLIM4;LPL;HSD11B1;S100A6;ZBTB38;TNNC1;SETMAR;FGFR1;UBA5;EEA1;SNX9;TGFB2;CLN6;ATG7;SNX2;CYP2R1;PSMF1;TPST1;SPPL3;GGCT;ABCG4;DPYD;SMAD3;MKLN1;TPM4;FMR1;SMAD4;XPNPEP3;PDCD10;PEX11A;RIPK1;ALDH3A2;IL6R;PANK1;NR6A1;ALS2;POU3F3;STK4;TCF3;PLEK;CRPPA;ZDHHC3;SH3GLB1;GNPTG;PTPA;AKT1;KLHL7
prerank,protein serine/threonine kinase activity (GO:0004674),0.3487827647948486,1.0826756857077702,0.29819277108433734,0.8389428143028215,1.0,99/335,22.19%,MAP3K14;NEK6;MAP4K4;TAOK1;MAST4;ERN2;LRRK2;ALPK1;PRKCA;MARK1;EGFR;KALRN;NUAK1;IRAK3;STK36;IKBKE;CASK;AKT3;CAMK2D;PRKD2;ACVR1;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;IRAK2;TAOK3;CDK10;HIPK4;NEK4;MAPK11;MAST2;ATR;TRIO;TGFBR1;MAP2K1;MYLK;CSNK2A1;CSNK2A2;RPS6KC1;MAP4K5;HIPK3;IRAK4;RPS6KB1;ACVR1B;CDC42BPA;GAK;NRK;CSNK1G2;CDK7;ACVR2A;MAP3K2;GSK3B;CSNK1A1;ACVR1C;MAP3K6;MKNK1;STK24;DAPK2;VRK3;RIPK1;PIK3R4;PRKDC;SQSTM1;MOK;STK4;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;BRD4;CDKL1;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;CDK9;CPNE3;FAM20C;CDK13;PLK2;PRKCD;PHKG2;BMPR1A;MAP3K20;CDK12;DYRK1A;VRK2;PKN1;PAK1;RPS6KA4;MARK2;CDC7;RAF1;LATS1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.534840726174413,1.0816128292880913,0.4012539184952978,0.8381836838538482,1.0,1/10,0.79%,EHHADH
prerank,protein heterodimerization activity (GO:0046982),0.3548806726242205,1.0809386454817524,0.34183673469387754,0.836371559553317,1.0,35/178,14.87%,SOHLH2;KRT25;TCF4;CREB3L3;SMC1A;NPAS4;EXT1;TENM3;IRAK3;USF1;ABCG1;BCL2;TAF7;EXT2;ZHX2;AHR;IRAK2;BCL2L2;ARNT;TENM4;ADD2;VAPA;BHLHE40;MIGA2;RRAGC;ITGA3;TOP2B;FBXO7;SNX2;MICU2;PSMF1;ABCG4;TPM4;FMR1;NOLC1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4579371854416699,1.07861199974112,0.387140902872777,0.8391295434167777,1.0,3/21,12.90%,P2RX5;GLRB;P2RX7
prerank,mechanosensitive ion channel activity (GO:0008381),0.5035907213100521,1.0759899313146999,0.41602465331278893,0.8429643049789105,1.0,2/12,4.18%,TMC3;PIEZO2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.39906246320828404,1.0749001032548928,0.36835748792270534,0.8422221223173192,1.0,7/47,11.38%,SLC7A2;SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.49766160792640435,1.072679219087816,0.4123867069486405,0.8446559930765902,1.0,4/12,19.71%,DHRS4;AIFM2;NDUFS7;DCXR
prerank,nucleosomal DNA binding (GO:0031492),0.4587579328667631,1.0723294518977884,0.3763586956521739,0.8418618748562496,1.0,10/21,21.54%,MBD2;SMARCC1;HDAC1;MTA2;GATAD2B;RCC1;SMARCA4;MBD3;HMGA2;HNRNPC
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.3113297776756197,-1.0697860955717553,0.3119266055045872,0.7880853045404652,1.0,19/35,28.35%,TRMT9B;DTWD2;DUS4L;MTFMT;TRDMT1;PUS10;GATB;NT5C3A;QTRT1;LCMT2;TRMT5;ELAC1;QRSL1;MRPL58;GATC;TYW3;TRMT12;AARS1;DUS3L
prerank,palmitoyltransferase activity (GO:0016409),-0.32998774988191537,-1.0691518994992013,0.354978354978355,0.7812609334546219,1.0,8/28,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC5;ZDHHC15;ZDHHC2
prerank,fatty acid synthase activity (GO:0004312),-0.45865279518784713,-1.0684491710744437,0.3877005347593583,0.7747811040222949,1.0,5/10,22.99%,ELOVL7;ELOVL5;ELOVL4;CBR4;OXSM
prerank,chemoattractant activity (GO:0042056),0.43622838464484087,1.0668311230164078,0.39080459770114945,0.853474220582785,1.0,11/26,21.76%,FGF7;CCL5;CXCL10;GPNMB;HMGB2;VEGFC;FGF2;CX3CL1;CCL15;GDNF;VEGFB
prerank,single-stranded DNA binding (GO:0003697),0.36715127355090077,1.0633103681130778,0.3928182807399347,0.8595834225620148,1.0,15/93,11.85%,RAD51B;RBMS1;RAD52;MCM2;DDX11;SUB1;FUBP1;MCM7;RAD23A;RAD23B;SETMAR;FBH1;HMGB2;MCM9;TDP2
prerank,phospholipase C activity (GO:0004629),0.43477979583675314,1.0614081688854833,0.4069611780455154,0.8609332179431705,1.0,6/25,10.87%,PDIA3;EDNRA;CCR1;CCL5;PLCL1;PLCB3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.41431540452035365,1.054748301738308,0.4165588615782665,0.8758734267650838,1.0,2/30,2.96%,KNG1;BIRC3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3414036489719151,1.053217529511037,0.322,0.8761802597313475,1.0,84/431,17.22%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;RND3;TAOK1;PEAK1;ERN2;RHOJ;LRRK2;MARK1;P2RX5;IRAK3;RAB2A;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;TUBG1;ACVR1;RHOD;GNL1;PYGL;MVK;RAB42;RALA;CDK6;RAP2A;ATL2;PLK1;RAB21;CDC42;VPS4A;CARS2;RAB7A;ABCE1;PXK;MAST2;RRAGC;PSMA6;TGFBR1;GUK1;RAB9A;MAP4K5;TARS1;MLKL;RAB32;RAB27B;GBP7;ACVR1B;RERG;CDC42BPA;GALK1;ARF4;GNAI1;RIT1;GCK;RHOA;GNL3;P2RX7;RAB10;MAP3K6;ARF1;MKNK1;DAPK2;RAC1;HSPA5;TRIB1;ANXA6;RHOF;STK4;TUBG2;ACVRL1;PNKP;PEX6;MTREX;PTPA;AKT1;LATS2
prerank,phospholipase inhibitor activity (GO:0004859),0.5225951848531959,1.0530830789331735,0.43661971830985913,0.8727136154969856,1.0,6/10,31.21%,ANXA1;ANXA9;ANXA5;ANXA2;APOC1;ANXA4
prerank,SH3 domain binding (GO:0017124),0.37889415927765785,1.0499456206776938,0.3954022988505747,0.8776174351800888,1.0,9/62,8.42%,CBLB;SH3BP2;ADAM12;DPYSL3;WIPF1;KHDRBS1;ABI2;CBL;GRB2
prerank,gamma-tubulin binding (GO:0043015),-0.3491720298169755,-1.0488806467024938,0.3767605633802817,0.8201402569515125,1.0,10/22,29.72%,DIXDC1;TUBGCP3;BRCA2;OFD1;GIT1;CDK5RAP2;BLOC1S2;RACGAP1;RAD51D;B9D2
prerank,magnesium ion binding (GO:0000287),0.35213961024115925,1.0488712237100073,0.3962655601659751,0.8768716185889253,1.0,21/135,13.58%,NEK6;PDXP;ERN2;LRRK2;PPA1;MARK1;IRAK3;ADCY2;EPHX2;MVK;FOXK2;RAP2A;PLK1;MAST2;RRAGC;IDH2;CDC42BPA;GNAI1;TDP2;ADPRH;MAP3K6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3727936870820222,1.0482226009122013,0.41103603603603606,0.8749324638395543,1.0,27/71,20.59%,PTPN7;PTPN3;PTPN13;PTEN;PTPRZ1;PTPN6;HACD2;PTPN18;PTPN1;PTPRJ;PTPN23;PTPN9;PTPN2;PTPRM;DUSP26;UBASH3B;CDC14A;TIMM50;PALD1;PTPRC;PTPN5;PTPRA;MTMR3;MTMR6;CDC14B;DUSP11;DUSP15
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.3763035370583442,-1.0480231871595422,0.3834808259587021,0.8055724202181187,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.3763035370583442,-1.0480231871595422,0.3834808259587021,0.8055724202181187,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,1-phosphatidylinositol binding (GO:0005545),0.4750091941186354,1.0460853132790775,0.42074074074074075,0.8771018160095325,1.0,8/15,20.47%,SESTD1;WDFY3;EEA1;SNX9;SNX10;PICALM;ZFYVE16;ZFYVE1
prerank,"DNA binding, bending (GO:0008301)",-0.38944644546105567,-1.0453255787544162,0.37755102040816324,0.8042954558940851,1.0,5/14,19.57%,LEF1;FOXD1;FOXL1;TFAM;HHEX
prerank,MAP kinase kinase activity (GO:0004708),0.4698377322860163,1.0446342469427763,0.42857142857142855,0.8774763937885638,1.0,3/15,9.11%,LRRK2;MAP2K4;MAP2K1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3752994216317214,1.042766458695713,0.4133180252583238,0.8789798114765661,1.0,11/56,11.03%,CBLB;GAB2;IRS1;NCK1;PTPN1;SH2B2;ANGPT1;CBL;FRS2;PTPN2;SOCS5
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.39278445184687627,1.0416218149477243,0.41566265060240964,0.8784687085289201,1.0,8/46,16.66%,MGAT5;EXT1;EXT2;OGT;MGAT4A;GCNT2;PIGP;B3GNT9
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.3063075231335597,-1.041477947004227,0.355,0.7988668828171874,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.3063075231335597,-1.041477947004227,0.355,0.7988668828171874,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3961204230351377,-1.0412175159395376,0.39197530864197533,0.7916414385704043,1.0,3/12,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,ubiquitin binding (GO:0043130),0.368142895658981,1.0411340327549643,0.42524916943521596,0.8760765441204975,1.0,19/73,17.55%,TNFAIP3;OTULINL;ILRUN;RAE1;CKS1B;TOM1L1;FBXW7;RAD23A;CXCR4;RAD23B;USPL1;FBXO7;NBR1;RNF19B;SMAD3;NEDD4;SQSTM1;RBCK1;MDM2
prerank,translation initiation factor activity (GO:0003743),0.40689978947816907,1.0407154106088017,0.4168765743073048,0.8734897751639368,1.0,14/36,24.24%,EIF4G2;EIF4G3;EIF4A1;EIF3H;EIF5B;EIF5;EIF1;EIF2B3;EIF3K;AGO2;EIF4G1;EIF3E;EIF2S1;EIF2A
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38582064391658527,1.0397044540270537,0.44205495818399043,0.8728339020593092,1.0,11/49,16.50%,TNIP1;TNFAIP3;IKBKE;BABAM2;BAG6;RAD23A;RNF169;RAD23B;EPS15;SQSTM1;ATRIP
prerank,alanine transmembrane transporter activity (GO:0022858),0.4879375761473927,1.0388622089149324,0.44,0.8713354850874336,1.0,3/12,9.69%,SLC38A3;SLC36A2;SLC7A8
prerank,CoA hydrolase activity (GO:0016289),0.4645297019711813,1.0384276299052435,0.4329004329004329,0.8688243725659888,1.0,5/16,22.83%,HIBCH;ACOT13;ACOT9;NUDT7;ACAA2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4142100350613338,-1.037871034691892,0.3956639566395664,0.7929622915303565,1.0,3/11,28.05%,SLC5A3;SLC2A9;SLC17A5
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.39349624770011293,-1.0337106595777943,0.38186813186813184,0.7960881072330029,1.0,5/13,12.33%,EZR;PRKAR1A;PRKAR2A;PKIA;KCNQ1
prerank,GTPase regulator activity (GO:0030695),0.33817151965348985,1.0331652598633703,0.41886409736308317,0.8796883131806671,1.0,48/212,16.40%,DLC1;RGS16;SYDE1;SEC23A;ARHGAP15;LRRK2;ARHGAP24;VAV3;NRP1;ARHGAP32;ARHGAP42;SIPA1L3;ASAP1;ASAP3;DOCK1;ERRFI1;ARFGAP3;TBC1D16;NF1;OPHN1;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;GPSM2;LLGL1;TBC1D8B;EIF5;RABGAP1;RAB3GAP2;PREX1;RALGDS;PDE6D;RIN2;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;ACAP2;ARHGAP35;TBC1D10B;RTKN;SIPA1L2;ALS2;ARHGAP9;ITGB1BP1;RASA1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3927095634441646,-1.032760246332185,0.4110429447852761,0.7909333384515977,1.0,3/14,4.59%,KCND3;KCNJ2;KCNJ3
prerank,phosphatase activator activity (GO:0019211),0.4626319544652009,1.0316223960972648,0.4329004329004329,0.8803810710747889,1.0,10/14,27.73%,FRS2;PPP2R5A;GTF2F1;CALM2;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,voltage-gated calcium channel activity (GO:0005245),0.40359189379166527,1.0307308536438304,0.4379001280409731,0.8791710961887412,1.0,5/37,5.01%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.35302323822416526,1.0286249982152287,0.4315217391304348,0.881193206404154,1.0,18/91,16.09%,SVIL;SH3PXD2B;MYO1B;SLC9A1;WIPI1;MARK1;SESTD1;TIRAP;MAPKAP1;GBF1;SNX18;EXOC1;VILL;KIF16B;PLEKHA5;WDR45;PLA2G4E;CGAS
prerank,disordered domain specific binding (GO:0097718),0.42824464659972844,1.0276738472169278,0.43454790823211875,0.8800744443168873,1.0,5/23,13.64%,CLTC;SMAD2;BCL2L2;GAPDH;CALM2
prerank,cGMP binding (GO:0030553),-0.4207682352540068,-1.0260709990847388,0.4505208333333333,0.8017930493377025,1.0,4/11,16.91%,RAPGEF2;PDE10A;PDE2A;PDE11A
prerank,cardiolipin binding (GO:1901612),0.50266509486991,1.0218367076588046,0.42586750788643535,0.8920935499612771,1.0,1/10,2.82%,STOML2
prerank,growth factor activity (GO:0008083),0.3620463944857123,1.020806326106919,0.43847874720357943,0.8910503966870543,1.0,10/74,13.23%,CXCL1;PTN;FGF7;JAG1;MDK;EGF;IL7;VEGFC;FGF2;BTC
prerank,mRNA methyltransferase activity (GO:0008174),0.4808166036089566,1.020287159890155,0.45037037037037037,0.8888372854131812,1.0,8/12,31.41%,METTL16;TRMT61B;TRMT61A;PCIF1;RNMT;METTL14;METTL8;NSUN2
prerank,G protein-coupled receptor activity (GO:0004930),0.3344808589920256,1.020255381109125,0.4499494438827098,0.885358520066543,1.0,25/239,12.75%,MC5R;P2RY10;GPR176;CMKLR1;GPR63;PDGFRB;ADGRL3;RXFP2;ADCYAP1R1;GLP2R;S1PR3;P2RY14;GPR161;S1PR2;CXCR4;DRD3;HRH1;TM2D1;LPAR3;OPN1MW;OPN1MW3;LPAR2;CALCRL;TAPT1;MC1R
prerank,DNA replication origin binding (GO:0003688),0.41981912918487274,1.020221179249528,0.45225464190981435,0.8819113556283613,1.0,5/23,10.37%,MCM2;DDX11;MCM7;GRWD1;MCM9
prerank,GDP binding (GO:0019003),0.3648593385972685,1.0201694713299652,0.45361990950226244,0.8785367277874961,1.0,14/63,13.50%,RAB2A;RAB42;RALA;RAP2A;RAB21;RAB8B;RAB7A;RRAGC;RAB9A;RAB27B;RERG;GNAI1;RIT1;RAB10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4991255963441343,1.0199617161833745,0.4439178515007899,0.8755816728826248,1.0,1/10,3.07%,DPYSL3
prerank,telomerase RNA binding (GO:0070034),0.42806270532635204,1.0196416607672985,0.43338008415147267,0.8729815985756385,1.0,10/22,21.54%,SMG7;PINX1;TERT;SMG6;DCP2;XRN1;TEP1;PARN;SNRPB;HNRNPC
prerank,galactosyltransferase activity (GO:0008378),0.493760791849177,1.0189095002421207,0.4488549618320611,0.871545109490046,1.0,4/11,17.68%,B4GALT5;B4GALT2;B4GALT7;B4GALT4
prerank,ion channel activity (GO:0005216),-0.24949045683268806,-1.0186684637620702,0.4144144144144144,0.8144807750417772,1.0,19/80,16.55%,TRPM3;TRPM6;GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;ABCC9;GRIA1;TMC7;MCUB;GRIN2D;GRIN2B;TRPV2;TMC6;TRPV4;NALCN;GRIK2;CHRNB1
prerank,syntaxin binding (GO:0019905),0.3677988258950134,1.0181335674646834,0.44583808437856326,0.8701494617751903,1.0,8/61,11.00%,ABCA1;CACNA1A;LRRK2;STX6;STXBP1;SYT2;STXBP3;PTPN2
prerank,adenyl ribonucleotide binding (GO:0032559),0.3302056890330821,1.01776178632264,0.4578313253012048,0.8678146563214749,1.0,38/291,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;RAPGEF4;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.410522264447466,1.017729707198973,0.44576719576719576,0.8645369837418692,1.0,5/29,11.67%,TNIP1;DUSP2;DUSP5;PTPRJ;NBR1
prerank,motor activity (GO:0003774),0.3694504272718893,1.0177249977573177,0.44533947065592633,0.8612079883728119,1.0,16/60,17.50%,KIF26B;KIFC1;KIF1C;MYH9;KIF13B;KIF2A;APPBP2;KIF5B;DYNC2H1;KIF16B;KIF27;MYO1E;GPR88;KIF5A;KIF9;KIF20A
prerank,hexosyltransferase activity (GO:0016758),0.3491622237991569,1.0167782231252114,0.4631803628601921,0.8602705399701135,1.0,20/101,18.25%,CHSY3;B4GALNT2;B4GALT5;EXT1;EXT2;B4GALNT1;ALG5;OGT;MGAT4A;CHSY1;GCNT2;DPY19L3;POGLUT3;TMTC4;CHPF2;B4GALT2;B4GALT7;B3GNT9;B4GALT4;FUT4
prerank,phospholipase activity (GO:0004620),0.3638098198888814,1.0166768961579484,0.46215596330275227,0.8572990023822995,1.0,16/67,16.48%,LIPC;ASPG;PDIA3;LPL;PLCL1;PLD4;PLA2G12A;PLCB3;ABHD16A;SEC23IP;LYPLAL1;SMPD3;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,death domain binding (GO:0070513),0.482594682630088,1.0161335904782367,0.45671641791044776,0.8553434977098416,1.0,2/11,4.98%,DAP;BCL2
prerank,single-stranded DNA helicase activity (GO:0017116),0.4368936545266633,1.0149044388960897,0.4553314121037464,0.855101213342664,1.0,3/19,8.70%,DNA2;MCM2;MCM7
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4228453546261259,-1.009541295410471,0.4378238341968912,0.8304119188964311,1.0,7/10,33.94%,DSEL;GALM;RENBP;DSE;GALE;FUOM;RPE
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3769775866704962,1.0086962250889784,0.4631578947368421,0.8677861071591338,1.0,16/53,20.08%,STEAP4;ETFA;MTHFR;POR;ACOX1;AIFM2;PPOX;ACOX3;DPYD;AIFM1;MTRR;XDH;CYBB;KDM1A;CYB5R3;SQOR
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.42370194015535023,-1.0067111568309757,0.4593908629441624,0.829760578469733,1.0,6/10,30.09%,ANKRD13A;IDE;FAAP20;FAN1;DNAJB2;ANKRD13D
prerank,retinoic acid binding (GO:0001972),0.4656797861583346,1.0054774919304967,0.44753086419753085,0.8728976066843872,1.0,1/12,4.15%,NR2F2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.4080783534899332,1.0046428232032114,0.4609271523178808,0.8717771912370346,1.0,1/27,0.13%,SLC39A14
prerank,GTPase activator activity (GO:0005096),0.3263496961684068,1.0046136814329787,0.4959839357429719,0.8686026085489423,1.0,73/313,16.62%,DLC1;RGS16;SYDE1;FARP2;SEC23A;VAV2;ARHGAP15;FARP1;LRRK2;MYCBP2;ARHGAP24;VAV3;RAPGEF4;NRP1;ARHGAP32;CYTH3;ARHGAP42;SIPA1L3;KALRN;ASAP1;ITSN1;ASAP3;DOCK1;ERRFI1;ARFGEF2;RABIF;ARFGAP3;TBC1D16;NF1;NUCB2;OPHN1;FGD4;EGF;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;LLGL1;DENND4C;TBC1D8B;RABGAP1;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;RGS10;TBC1D1;SMCR8;ADPRH;SH3BP5L;RAB3GAP1;ANKRD27;ARHGAP22;ACAP2;ARHGEF18;ARHGAP35;TBC1D10B;DNMBP;SIPA1L2;ALS2;RCC1;ARHGAP9;RGL1;EIF2B3;RASA1;DOCK2;LAMTOR5
prerank,amino acid:sodium symporter activity (GO:0005283),0.4793762122794889,1.0029642034716395,0.4694533762057878,0.8694626786677992,1.0,1/11,0.63%,SLC1A3
prerank,voltage-gated anion channel activity (GO:0008308),-0.36580492415359656,-1.0014260839393325,0.45317220543806647,0.8367174555818406,1.0,5/15,7.65%,GPR89B;GPR89A;CLCN2;CLCN3;VDAC1
prerank,pre-mRNA binding (GO:0036002),-0.30176941673339497,-1.0012064862573862,0.4,0.8298562015129838,1.0,6/28,11.96%,DDX5;CELF2;HNRNPU;U2AF2;SNRPC;HNRNPA1
prerank,cyclic nucleotide binding (GO:0030551),-0.3343077024963773,-0.999453513102953,0.4460431654676259,0.8270012581927014,1.0,7/21,17.77%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A;PDE11A;HCN1
prerank,histone methyltransferase activity (GO:0042054),0.3921096343723512,0.9989345223451451,0.4578469520103761,0.8763418488936291,1.0,14/32,25.64%,KMT5A;EHMT1;CARM1;SETD2;SETDB1;KMT2E;NSD3;N6AMT1;SUZ12;DOT1L;PRMT5;KMT2C;SETD7;KMT5B
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.40027768088049703,-0.9982599932247618,0.4823529411764706,0.8226078973785019,1.0,3/12,4.70%,CDH5;VEGFD;CCDC88A
prerank,phosphatidylinositol binding (GO:0035091),-0.23966461752376733,-0.9962798009042626,0.47619047619047616,0.8202925537020329,1.0,25/91,17.80%,PITPNC1;MCF2L;EPB41;DENND1A;ITPR2;PITPNM2;PITPNA;HIP1R;ESYT2;CCDC88A;ESYT1;SCARB1;PLEKHF2;ITPR3;PARD3;SNX16;TNFAIP8L3;HIP1;GPAA1;ESYT3;MREG;SNX11;SNX13;FCHO2;SNAP91
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4701369504731825,0.9918937608297271,0.49019607843137253,0.8912616425219797,1.0,7/12,26.60%,PHF2;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,Hsp70 protein binding (GO:0030544),0.3978139104803966,0.9918203677825618,0.5050251256281407,0.8881841274420245,1.0,5/31,9.08%,SPN;DNAJB1;IQCG;PPID;CYP1A1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.46330066857834656,0.9890444913808166,0.5172932330827068,0.8917768997804957,1.0,5/13,16.71%,GPSM2;ARHGDIG;EIF5;ITGB1BP1;ARHGDIA
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4447862462514905,0.9882400715397406,0.4817073170731707,0.8903663721005496,1.0,3/15,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.32201725140685294,0.986230768123055,0.5488418932527693,0.891887500931205,1.0,59/269,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;STAT1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;DDRGK1;SMAD3;UBE2W;EGR2;TRIB3;RPL11;DTX3L;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;ITCH;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.42596330368813723,0.9857283157049822,0.5062586926286509,0.8899329452602122,1.0,3/18,9.05%,ALDH18A1;ALDH1A2;HSD17B12
prerank,death receptor activity (GO:0005035),0.4677134657500768,0.982593605419999,0.4930662557781202,0.8945434876676763,1.0,3/11,11.94%,EDA2R;TNFRSF1A;TNFRSF4
prerank,manganese ion binding (GO:0030145),0.3663254792382752,0.9814867163002756,0.483451536643026,0.8940860749695624,1.0,8/48,15.52%,MGAT5;GALNT3;ADCY2;XPNPEP1;NEK4;TDP2;XPNPEP3;B4GALT7
prerank,channel activity (GO:0015267),0.376333287662062,0.9811344887189541,0.49572649572649574,0.8917669914655763,1.0,7/41,18.56%,P2RX5;TMEM120B;BCL2;TMEM266;PDPN;TMEM120A;PANX1
prerank,nuclear localization sequence binding (GO:0008139),0.43180933569101304,0.9803638841005511,0.5201149425287356,0.8904513713625748,1.0,8/18,23.09%,KPNA3;BRAP;NUP153;TNPO1;NFKBIA;NUP214;KPNA2;KPNB1
prerank,carboxy-lyase activity (GO:0016831),-0.3143979488619108,-0.9795774474469148,0.5090252707581228,0.8590794959429775,1.0,7/23,25.24%,PPCDC;ECHDC1;DDC;GAD1;CSAD;UXS1;MLYCD
prerank,N-acetyltransferase activity (GO:0008080),0.4255837723269013,0.9786421097284819,0.502177068214804,0.8915306434220185,1.0,3/19,10.81%,NAT1;NAA50;NAT10
prerank,methyltransferase activity (GO:0008168),0.3578397276380552,0.9760453305656381,0.5029940119760479,0.8945212669663279,1.0,15/46,24.63%,ASMT;AMT;EHMT1;DNMT3B;MRM2;MGMT;COQ5;COMT;PRMT3;BCDIN3D;N6AMT1;FTSJ3;NDUFAF7;PRMT5;COQ3
prerank,SUMO binding (GO:0032183),0.44510854598015437,0.9759718612011415,0.5061162079510704,0.8915224307961505,1.0,3/13,9.91%,CASP8AP2;RNF111;USPL1
prerank,RNA binding (GO:0003723),0.3122285896444942,0.9759332716386285,0.625,0.8884746621703082,1.0,335/1321,22.00%,RBMS3;IGF2BP1;ZBP1;DCN;FNDC3B;RBM46;POU5F1;CLTC;BICC1;RPSA;RRBP1;RBMS1;RFTN1;C1D;LRP1;RPUSD3;ALDH18A1;ZFP36L1;IGF2BP2;APOBEC1;RBFOX1;EIF4G2;MAK16;CCAR1;CSRP1;SYNCRIP;ZFP36L2;ATXN2;ZCCHC24;AFF2;PDIA3;EIF4G3;SMC1A;DNA2;SREK1;DNTTIP2;ASCC3;MRPS26;RPL3L;ARCN1;NOL11;STAT3;FSCN1;ILF3;DYNC1H1;PPRC1;KIF1C;MYH9;ZC3H13;KHDRBS1;PUM1;SNRNP40;DNAJC21;SERPINH1;SMG7;ZFR;SPATS2;PES1;SELENOH;XPOT;TENT5A;SHFL;RAE1;ARL6IP4;SNTB2;CNOT4;CSTF1;METTL16;EIF4A1;ERI1;MYO5A;EIF2AK2;DDX11;ENO1;DHX35;YARS1;PTBP3;STXBP1;CCDC86;TLR7;DAP3;PINX1;SUB1;TRUB2;ACO1;PDAP1;DDX17;NOC2L;EIF3H;HSPE1;CAPRIN1;PTPN1;GIGYF2;FUBP1;ZC3H15;POP1;RRP1B;RRP1;DIDO1;CANX;SAMD4A;AIMP1;NMD3;CCAR2;PABPC4;CKAP4;MSN;CELF1;BUD13;TERT;TNRC6B;GRB2;SMG6;EIF5B;UBFD1;SAP18;EIF5;CCDC9B;PSMA6;DCP2;MTERF4;NONO;RNASEH1;SEC63;DICER1;SND1;NOP14;UBE2L3;OASL;DHX34;DHX8;GRWD1;NOP2;HMGB2;PELP1;NIP7;ALKBH5;NCBP2;ALKBH1;HNRNPH2;DDX28;RAMAC;UTP3;CCDC59;NAT10;CHD2;MOV10;SEC23IP;XRN1;DMGDH;YWHAZ;TNPO1;RPL12;CS;STAU1;MRM1;RCAN3;MTIF2;SNRNP35;SAFB;TRAP1;CALR;ANKRD17;ZCCHC8;RARS2;UBAP2L;SRP68;DDX31;POP4;AGFG1;ANP32A;HEATR6;GNL3;IREB2;SRSF12;RPL22;RPL14;SAFB2;MRPL15;NUDT4;GTF2F1;LSM14B;COL14A1;YBX3;NSRP1;ARF1;RBM6;ELP1;ZCCHC17;MRPS14;YTHDF3;FMR1;RBM10;CCT3;PPHLN1;CPEB4;RPL11;HELZ;AKAP1;DCP1A;BAZ2A;NOLC1;SNRNP200;DXO;PATL1;NAA15;KYAT3;SETX;GSPT1;RTRAF;FLNB;CTNNA1;RBM28;PRPF31;WDR36;NOP16;BYSL;TRIM56;RPN1;LSM7;EIF1AX;EIF1;PRKDC;RBMX;MAP4;SLC4A1AP;SRP14;DDX50;RSRC2;HNRNPUL1;BAG4;RBM47;FNDC3A;RPF1;DHX29;SIDT2;POLRMT;TEP1;PRRC2C;HSPD1;MTREX;NUCKS1;DHX15;RC3H2;TCERG1;THRAP3;YWHAE;RBFOX2;ZNFX1;DDX1;ZCCHC7;RPL36A;ZNF346;TUT7;NUDT7;RPS9;SRFBP1;PRPF3;USP36;MSI1;DDX20;R3HDM1;RBM15;SPEN;CDC42EP4;RBM39;SRSF2;SPTBN1;HSP90B1;TBL2;CPNE3;PARN;GANAB;FASN;MBNL2;SON;RPL6;SRP72;TASOR;MRPS27;EFTUD2;PUF60;KDM1A;CELF5;AGO2;FARS2;SNRPB;LGALS1;MYEF2;DUS2;ETF1;KPNA2;NAP1L1;CDK13;ATP5F1A;DUSP11;HNRNPDL;POLR1G;CAST;UTP11;RBM4B;EIF4G1;ZC3H12B;ACTN1;RBMS2;SCAF11;DDX24;BZW1;NEMF;TOP3B;DHX57;LYAR;YY1;CSDE1;MAP3K20;ZC3H12A;ZRANB2;ERI3;DHX37;BMS1;FAM133B;HNRNPC;RPS27A;KRI1;YBX1;CLUH;FTSJ3;RBBP6;SCAF4;MARK2;RSL1D1;ANKHD1;DDX10;FYTTD1;USO1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3149990970312875,0.9758699178817143,0.5925553319919518,0.8854983987867431,1.0,65/346,16.63%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;TNFAIP3;BIRC3;CUL1;SMURF2;UBR5;TRIM21;UBR4;RNF2;CNOT4;RNF144A;ANAPC11;CDC42;SIAH2;MIB1;RNF111;KLHL13;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;UBE2L3;PELI3;TRIM44;UBE2R2;NEURL2;UBE2J1;FBXO7;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;RNF149;UBE2K;TRAF2;KCMF1;MAEA;UBE2W;FBXO2;RNF11;DTX3L;RNFT2;RNF141;SMURF1;ITCH;NEDD4;TRIM56;PELI2;RBCK1;TRAIP;TRAF3IP2;TRAF5
prerank,protein kinase C activity (GO:0004697),-0.37844438407230796,-0.9747478136620636,0.48493975903614456,0.8638807061831156,1.0,3/14,4.77%,PRKCH;PRKCZ;PRKCB
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3440895017022592,0.9747397820086239,0.52423900789177,0.885072442443497,1.0,24/74,20.26%,PAPSS2;DCAKD;HK2;FAM20A;MVK;TRPT1;DGKH;GALK2;ADPGK;PANK2;GALK1;GK;KHK;PI4KA;SPHK2;COASY;PANK1;NADK;FAM20B;PIK3C3;POMK;FAM20C;HYKK;ETNK1
prerank,C-C chemokine receptor activity (GO:0016493),0.4055399719079181,0.9685393141383539,0.5149456521739131,0.8968086052430948,1.0,2/21,9.00%,CCR1;CXCR4
prerank,ubiquitin protein ligase binding (GO:0031625),0.3170027173514576,0.9679838195069671,0.5832492431886983,0.8948496332745576,1.0,55/254,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;SMAD3;UBE2W;EGR2;TRIB3;RPL11;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,kinase activator activity (GO:0019209),-0.28831477380394294,-0.9675859065589651,0.49356223175965663,0.8754543199335394,1.0,3/30,4.99%,PRKAG2;MALT1;MADD
prerank,cation transmembrane transporter activity (GO:0008324),0.35795283567295194,0.9666579216884957,0.5226190476190476,0.8948061288029053,1.0,2/48,1.81%,SLC7A2;SLC38A3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.45162969584507434,0.9656222710899318,0.5279106858054227,0.8938758752996367,1.0,8/12,23.93%,CDK6;CDK7;MAPK1;BRD4;CDK9;CDK13;CDK12;CDK8
prerank,histone methyltransferase binding (GO:1990226),0.4593554794329397,0.9650753238481131,0.5023474178403756,0.8920582919960054,1.0,4/11,17.87%,PHF1;LCOR;LCORL;PRDM4
prerank,3'-5' DNA helicase activity (GO:0043138),0.4270444936371302,0.9647900927316014,0.49053857350800584,0.8897201326702662,1.0,4/16,10.03%,ASCC3;MCM2;MCM7;FBH1
prerank,phosphate ion binding (GO:0042301),-0.40793643480886765,-0.964049167776372,0.5261707988980716,0.8771807356809896,1.0,4/10,31.92%,PDE2A;MTHFD2;ADSS1;RPH3A
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4438597949694718,0.963974068756785,0.5250379362670713,0.8885156729453615,1.0,2/13,9.55%,DNA2;DICER1
prerank,microtubule motor activity (GO:0003777),0.35480408028764265,0.9634875121318427,0.5145180023228804,0.8866963793513707,1.0,6/51,6.00%,KIF26B;KIFC1;KIF1C;KIF13B;KIF2A;APPBP2
prerank,mRNA binding (GO:0003729),0.3162032799072825,0.9618073205031957,0.5787878787878787,0.8877047238305089,1.0,36/249,14.89%,RBMS3;IGF2BP1;RBM46;RBMS1;ZFP36L1;IGF2BP2;RBFOX1;EIF4G2;SYNCRIP;EIF4G3;KHDRBS1;PUM1;CPEB1;SHFL;EIF4A1;PTBP3;CARHSP1;ACO1;FUBP1;SAMD4A;PABPC4;CELF1;NCBP2;SNRNP35;CALR;MARF1;GNL3;IREB2;LSM14B;YBX3;NSRP1;YTHDF3;FMR1;CPEB4;DCP1A;DXO
prerank,LRR domain binding (GO:0030275),0.43708610626502764,0.9579648248598995,0.5414110429447853,0.8932850200103533,1.0,4/14,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.34841857092464495,0.9575145268085711,0.5348288075560803,0.8912060227797783,1.0,10/55,16.24%,SLC7A2;SLC38A3;SLC38A4;SLC16A12;SLC36A2;SLC7A8;PDPN;ABCC1;SLC25A10;SLC16A6
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.451261358300327,0.9548701863128249,0.5213414634146342,0.8942016965194161,1.0,1/11,3.41%,SLC25A47
prerank,signaling receptor complex adaptor activity (GO:0030159),0.36555386890469865,0.9541201700428397,0.5092250922509225,0.8928128620902313,1.0,10/38,14.72%,GAB2;LRRK2;IRS1;NCK1;NCK2;SH2B2;FRS2;PIK3R1;DLG5;MMS19
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4587662568686961,0.9541005795256405,0.5355450236966824,0.8898516432933825,1.0,2/11,5.13%,ITPR1;TRPC6
prerank,myosin binding (GO:0017022),0.34812953246667755,0.9539729941117893,0.5285215366705471,0.8871151659846559,1.0,11/55,13.50%,NKD2;MLPH;CALD1;TRAK1;RALA;LLGL1;CXCR4;RAB27B;RHOA;GIPC1;RAB10
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.46459264037298315,0.9510140932570723,0.5467289719626168,0.8908983948404113,1.0,3/11,12.85%,UBR5;ANAPC11;UBE2K
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3246790461007354,-0.9508545830814276,0.53,0.9045634793363022,1.0,3/17,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.40224103983546033,0.9499207357381139,0.5367847411444142,0.8906132265632044,1.0,6/22,20.59%,DUSP2;DUSP5;DUSP6;MTMR3;MTMR2;DUSP15
prerank,tropomyosin binding (GO:0005523),-0.34605169913768374,-0.9497357040628657,0.5387323943661971,0.9000523295116728,1.0,2/16,3.95%,NEBL;TMOD3
prerank,DNA polymerase activity (GO:0034061),0.40580107748957106,0.9492403566437297,0.5459533607681756,0.8891156789113152,1.0,5/22,15.53%,POLE3;TERT;POLI;REV1;POLG
prerank,voltage-gated ion channel activity (GO:0005244),0.4337285870315539,0.9484943015339385,0.524300441826215,0.8879142473189026,1.0,3/14,5.25%,HVCN1;PKD2;VDAC2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3992496524286996,0.9462373097730957,0.543509272467903,0.8872720529146318,1.0,10/21,23.93%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3992496524286996,0.9462373097730957,0.543509272467903,0.8872720529146318,1.0,10/21,23.93%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,translation elongation factor activity (GO:0003746),-0.3580537393218738,-0.9461173036840771,0.5102040816326531,0.9020478531099521,1.0,8/14,36.78%,EEF1B2;GTPBP2;TSFM;EEF2;GFM1;TUFM;EIF5A;EIF5AL1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.30519238567495965,-0.9454894062420139,0.5772357723577236,0.8963641341309306,1.0,6/24,16.77%,GLUL;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC2
prerank,exonuclease activity (GO:0004527),0.353364178685949,0.9444825989332895,0.553921568627451,0.8882264358216964,1.0,5/46,8.81%,ENPP1;REXO1;ERI1;DCLRE1C;EXOSC4
prerank,peptidase activator activity (GO:0016504),-0.31791984094338116,-0.9431726657275366,0.572,0.8951317520714056,1.0,7/22,12.72%,CAV1;MAL;APH1A;VSIR;APH1B;PCOLCE2;PINK1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36422926975785286,0.942717382516739,0.5522755227552275,0.8890394916657925,1.0,9/35,15.26%,ENPP1;PLCXD3;PDIA3;PLCL1;PLD4;PLCB3;TDP2;SMPD3;SMPDL3B
prerank,histone acetyltransferase activity (GO:0004402),0.3742100939875732,0.9418307946479648,0.5428954423592494,0.8880414533540885,1.0,10/30,21.43%,BAZ1A;NAA50;CREBBP;EPC2;USP22;SRCAP;CLOCK;KAT6B;KAT7;TADA3
prerank,3'-5' exonuclease activity (GO:0008408),-0.2659635224778647,-0.9360623801530411,0.5555555555555556,0.9061734885129346,1.0,17/45,25.65%,MRE11;CNOT8;EXOSC7;APLF;CNOT6L;RAD1;EXOSC3;EXD1;ANGEL2;REXO4;TOE1;ANGEL1;PDE12;EXOSC10;NOCT;TATDN1;RAD50
prerank,cadherin binding (GO:0045296),0.30502800891485166,0.9355368673690728,0.6683417085427136,0.8986825656226538,1.0,84/315,17.95%,CDH11;MYO1B;EIF4G2;FMNL2;STAT1;GOLGA3;DNAJB1;CALD1;TNKS1BP1;EGFR;ASAP1;FSCN1;CHMP4B;MYH9;PARVA;LIMA1;BAG3;NCK1;BAIAP2;CEMIP2;DCHS1;ACVR1;ENO1;CDH6;VAPA;PTPN1;GIGYF2;ZC3H15;EPS15L1;CBL;UBFD1;EIF5;ANXA1;CCT8;LASP1;PPFIBP1;SND1;DBN1;MB21D2;CNN3;CLINT1;PLCB3;PTPRJ;SNX9;YWHAZ;CCNB2;CDH18;CDH24;RUVBL1;DBNL;PTPRM;SNX2;EPS15;NUMB;PI4KA;SNX5;KIF5B;RARS1;ABI1;PPME1;GIPC1;RPL14;RAB1A;RAB10;PCMT1;PSEN1;SRC;STK24;PHLDB2;HSPA5;CHMP2B;FLNB;CTNNA1;CDC42EP1;EXOC3;LYPLA2;SH3GLB1;DHX29;CSNK1D;YWHAE;CTTN;CKAP5;PICALM;CAPZA1
prerank,GTPase binding (GO:0051020),0.30436566958562994,0.9334962370542604,0.6320081549439348,0.900104788359419,1.0,50/195,18.76%,ABCA1;MLPH;LRRK2;MYCBP2;STOML2;RAPGEF4;AMBRA1;FGD4;MYO5A;ENO1;RABGAP1L;UNC13D;EXOC4;ABI2;AIMP1;MAPKAP1;GOLGA5;CHML;RRAGC;LCP1;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;ATG16L1;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;RASA1;CCDC186;GNB2;TBC1D20;PICALM;CDC42EP4;GNB1;EPS8;SPTBN1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3834768109807725,0.9333054116629892,0.5661375661375662,0.8976652374744263,1.0,7/25,16.56%,ATXN2;EGF;GRB2;ARF4;SNX2;BTC;SNX4
prerank,thioesterase binding (GO:0031996),0.45435255429277566,0.9331302399909553,0.5455974842767296,0.8951234876835266,1.0,4/11,16.63%,CDC42;TRAF2;RAC1;TRAF5
prerank,pyridoxal phosphate binding (GO:0030170),-0.3169690499132412,-0.932631787720435,0.543046357615894,0.9079230511838279,1.0,8/20,19.47%,ABAT;PYGM;PLPBP;PYGB;ACCS;PDXK;PSAT1;CBS
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.37723395516175773,0.9289886476597119,0.5469387755102041,0.9014677585283092,1.0,10/25,20.47%,GAB2;SESTD1;DAPP1;MAPKAP1;KIF16B;PLA2G4E;PLEK;AKT1;PLEKHA2;ZFYVE1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4513247420625141,0.9282420660558927,0.5690440060698028,0.9001249710113715,1.0,2/10,14.25%,CDKN2B;CDKN1B
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3348855624431892,-0.9278158657158109,0.5348101265822784,0.912998753865325,1.0,3/16,8.48%,SLC25A42;SLC25A26;SLC22A4
prerank,G protein-coupled receptor binding (GO:0001664),0.31394970042495846,0.9277823397188754,0.6272066458982347,0.8982011497805527,1.0,13/132,10.99%,WNT2;CXCL12;XCL1;WNT9A;ADM;CCL5;FZD1;SFRP1;LRP6;S1PR2;WNT5A;ARHGEF12;GNAI1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.38813208985227315,0.9270785882667296,0.5482093663911846,0.8967489199778088,1.0,4/21,15.70%,FGF7;FRS2;FGF2;FGF18
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.36844120958991167,-0.9257455353921029,0.5842391304347826,0.9109206012215197,1.0,3/11,11.11%,SRRM2;LEF1;GATA2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3705141832441353,-0.9255418627944494,0.5859154929577465,0.904255182869991,1.0,4/12,13.05%,PIK3R3;PIK3CB;PIK3R6;PIK3CD
prerank,sequence-specific mRNA binding (GO:1990825),0.4471178204753059,0.925273268248255,0.5640625,0.8976878709091402,1.0,4/10,24.52%,SHFL;FMR1;ETF1;TYMS
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.44430668900346854,0.9242915716814828,0.5863141524105754,0.8970082534291445,1.0,4/12,23.10%,OPN1MW;OPN1MW3;GPR88;RRH
prerank,acetylation-dependent protein binding (GO:0140033),0.4019770928686334,0.9233849436575009,0.5710382513661202,0.8932048587500774,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,lysine-acetylated histone binding (GO:0070577),0.4019770928686334,0.9233849436575009,0.5710382513661202,0.8932048587500774,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3895655426897105,0.9229348664911466,0.5338983050847458,0.8913268077808248,1.0,5/20,12.34%,CASK;DTYMK;GUK1;AK2;AK8
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3073891040840126,0.9228491504446522,0.6474820143884892,0.8887109487935675,1.0,38/147,16.62%,FARP2;VAV2;FARP1;MYCBP2;VAV3;RAPGEF4;CYTH3;KALRN;ITSN1;DOCK1;ARFGEF2;RABIF;NUCB2;FGD4;EGF;DENND4C;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;SMCR8;SH3BP5L;RAB3GAP1;ANKRD27;ARHGEF18;DNMBP;ALS2;RCC1;RGL1;EIF2B3;DOCK2;LAMTOR5
prerank,filamin binding (GO:0031005),-0.3661519120169645,-0.9225010644218357,0.5776566757493188,0.90435474670582,1.0,1/11,0.02%,NEBL
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3257126082376915,-0.9207111050604552,0.5602409638554217,0.8950540701740685,1.0,9/16,37.27%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3257126082376915,-0.9207111050604552,0.5602409638554217,0.8950540701740685,1.0,9/16,37.27%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,clathrin adaptor activity (GO:0035615),0.4129884337588611,0.9195672253497905,0.5669642857142857,0.8925029439227922,1.0,1/15,0.76%,STON2
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.23540548910995143,-0.9159552225167613,0.6363636363636364,0.9002100936556349,1.0,7/55,5.30%,SLC24A2;CACNB2;ITPR2;TMEM165;ATP2B4;ATP2B2;TMCO1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3837503788361827,0.9139637568704437,0.5939643347050755,0.9011770445312924,1.0,2/23,3.43%,PDE3A;PDE7B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39124940124968477,0.913866078057328,0.5949367088607594,0.8985985325794931,1.0,2/21,3.43%,PDE3A;PDE7B
prerank,deoxyribonuclease activity (GO:0004536),-0.3433708965725676,-0.9120435633876158,0.557632398753894,0.9036466309609223,1.0,3/14,7.93%,ERCC5;MRE11;APLF
prerank,ligand-gated calcium channel activity (GO:0099604),0.3987868187348577,0.9097416712693891,0.5856115107913669,0.9041788861031587,1.0,2/19,4.84%,RASA3;ITPR1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4156092176678345,0.9092793678501401,0.5672333848531684,0.9024948869340867,1.0,2/13,5.33%,PIP5K1B;PIP4K2A
prerank,proton transmembrane transporter activity (GO:0015078),0.34919917292642105,0.9089946116280834,0.5912408759124088,0.9003009485764946,1.0,7/39,11.34%,SLC9A1;SLC11A2;CLCN5;COX7A2L;DMAC2L;UQCRC1;ATP6V1F
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3408643757647458,-0.9067904614230927,0.5825825825825826,0.9099813444165638,1.0,3/13,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3299882813646986,0.9056532233946729,0.617269544924154,0.9042750946830024,1.0,20/60,22.75%,LRRK2;PTEN;CTDSPL2;LRRK1;LRRC39;PPP3CA;PPP1CB;ILKAP;PPP4C;CDC14A;TIMM50;PPP6C;PHLPP2;MTMR3;RPAP2;MTMR6;CDC14B;LRRC40;PPM1H;PPM1D
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.41933495277207633,0.9055061838871201,0.5979228486646885,0.9018576692311006,1.0,2/14,2.54%,FETUB;TIMP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3783483349723039,0.9051720674067282,0.6060191518467852,0.8997937656069459,1.0,5/22,16.50%,TNFAIP3;IKBKE;RNF169;SQSTM1;ATRIP
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.36965907087250266,-0.904395093662563,0.56353591160221,0.9087140048591675,1.0,8/11,52.86%,HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,single-stranded RNA binding (GO:0003727),-0.2519578879316427,-0.9029606625458124,0.6387434554973822,0.9053400460505736,1.0,15/43,22.00%,STRBP;HNRNPU;AQR;U2AF2;ADARB2;SNRPC;HNRNPA1;SRA1;POLR2G;EIF4H;CNBP;FXR1;IFIH1;AGO3;EXOSC10
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3953148913937004,0.9024819644054475,0.5902578796561605,0.9022910893124331,1.0,7/18,20.69%,ACVR1;TGFBR1;LTBP1;ACVR1B;ACVR2A;ACVRL1;BMPR1A
prerank,tRNA methyltransferase activity (GO:0008175),-0.32716739295706915,-0.9023872621218038,0.6109324758842444,0.9001039972688204,1.0,8/16,27.66%,ALKBH8;TRMT9B;TRDMT1;LCMT2;TRMT5;TRMT44;TYW3;TRMT12
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37467774105705526,-0.8994529436078341,0.5826086956521739,0.9006718397482263,1.0,4/10,19.38%,SLC24A2;SLC8A3;SLC8B1;SLC8A2
prerank,antiporter activity (GO:0015297),0.38744295474614404,0.8992505628298836,0.5986928104575163,0.905888796628736,1.0,7/20,23.98%,SLC25A16;SLC35C1;TMEM241;SLC35D2;SLC25A10;CLCN4;SLC35E3
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24023328129642185,-0.8966431587653819,0.6395348837209303,0.9013926959652127,1.0,8/49,8.42%,ANXA3;C2CD5;MCTP1;ESYT2;PCLO;ESYT1;DYSF;SYT7
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3136987753464281,0.8959842141710435,0.6432616081540203,0.9097076910036019,1.0,18/75,21.13%,EHHADH;DHRS4;AKR1A1;RDH12;RDH10;HSD17B8;KCNAB1;H6PD;GLYR1;UGDH;DHDH;ADH1A;SORD;IMPDH2;DHRS3;DCXR;ADH5;HIBADH
prerank,endopeptidase activator activity (GO:0061133),-0.36798197898985,-0.895792294926789,0.5925925925925926,0.8969552377666796,1.0,5/10,25.21%,APH1A;VSIR;APH1B;PSME1;ADRM1
prerank,protein kinase regulator activity (GO:0019887),0.3092044147752793,0.8956089320808802,0.6586433260393874,0.9077406747556647,1.0,28/95,22.63%,CCNE2;PARVA;NCK1;CCNL1;CCND3;CXCL10;TAOK3;GSKIP;RPTOR;PRKAR1B;TPX2;CCNB2;GMFB;FGF13;CCNI;SMCR8;SH3BP5L;CDKN1B;TRIB1;CCNT1;DNAJC3;MAPK8IP1;CCNL2;DUS2;SPRY4;MARK2;RGCC;CCNH
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3591887193267518,0.8950191209372951,0.5970548862115127,0.9061949909777844,1.0,4/24,12.34%,ITPKC;DTYMK;IP6K2;AK8
prerank,GTP binding (GO:0005525),0.29783170911736867,0.894519035567801,0.7063008130081301,0.9044626680844641,1.0,29/172,15.01%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,vitamin D receptor binding (GO:0042809),0.40856654149187865,0.8917084664478346,0.6259659969088099,0.9070664007962214,1.0,6/14,22.53%,TAF7;MED13;THRAP3;MED12;MED1;MED14
prerank,kinase activity (GO:0016301),0.30204262778376256,0.8910435046214199,0.6727272727272727,0.9056503980760039,1.0,24/109,17.14%,MAP4K4;PAPSS2;TAOK1;LRRK2;DCAKD;MVK;ITPKC;DGKH;FN3KRP;ADPGK;CSNK2A1;IP6K2;PANK2;GK;COQ8B;GSK3B;PI4KA;SPHK2;TRIB3;COASY;PANK1;NADK;PIK3C3;AKT1
prerank,C-C chemokine binding (GO:0019957),0.36586281380623586,0.8870034752787048,0.6137281292059219,0.9105477002570825,1.0,2/22,9.00%,CCR1;CXCR4
prerank,microtubule binding (GO:0008017),0.29007009666496963,0.8866381509104735,0.7484725050916496,0.9085907148503986,1.0,47/222,17.93%,KIF26B;MID1;KIFC1;MAP4K4;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;HOOK2;KIF2A;RAE1;ALMS1;PLK1;VAPA;MAST2;EML3;FAM161A;TPGS1;TPX2;GAPDH;MAPRE2;CFAP157;MACO1;FMN1;CAMSAP2;FBXW11;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.31210018293919856,0.8861505890583775,0.6670454545454545,0.9068436362072064,1.0,10/72,10.66%,SVIL;MYO1B;SLC9A1;MARK1;SESTD1;TIRAP;MAPKAP1;SNX18;EXOC1;VILL
prerank,pyrophosphatase activity (GO:0016462),0.33128917452480516,0.8856521220796806,0.6517647058823529,0.9050627704344306,1.0,10/50,17.85%,ENPP1;PPA1;DCP2;ENTPD7;NUDT14;NUDT4;ENTPD6;DXO;DHX29;NUDT7
prerank,protein phosphatase 2A binding (GO:0051721),0.3692059555682798,0.8837896167396737,0.6271870794078062,0.9059367412246213,1.0,8/23,20.13%,SMG7;STRN;PPME1;CTTNBP2NL;PTPA;ANKLE2;MFHAS1;STRN4
prerank,gap junction channel activity (GO:0005243),0.36757093824674203,0.8799239993421909,0.6204481792717087,0.9104507383447424,1.0,3/22,7.90%,GJC2;GJD3;GJC1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.32265588806376616,-0.8798904254981892,0.6375,0.928351006138367,1.0,1/16,0.62%,PIR
prerank,histone deacetylase binding (GO:0042826),0.3040221481481615,0.8784007009975875,0.6681175190424374,0.9107973176789569,1.0,22/88,19.93%,NCOR2;GLI3;SATB2;KCTD21;MIER2;USF1;ZMYND15;HDAC1;PRDM1;MTA2;TOP2B;LCOR;SPI1;DACT1;NIPBL;MTA3;YWHAE;RAD9A;HDAC5;BRMS1L;THAP7;KPNA2
prerank,ion gated channel activity (GO:0022839),0.3639631570882245,0.8781758797899425,0.6256684491978609,0.9085827639091255,1.0,6/24,20.68%,KCNT2;TRPM4;ANO10;TTYH1;ANO6;TMEM63B
prerank,N-methyltransferase activity (GO:0008170),-0.2993606505031571,-0.8764070342125007,0.6592592592592592,0.929782176837214,1.0,7/20,18.35%,ZCCHC4;TRMT1L;HNMT;TFB1M;PRMT1;DIMT1;NNMT
prerank,wide pore channel activity (GO:0022829),0.36318810927026957,0.8761077764239724,0.6293222683264177,0.9098889600603666,1.0,3/23,7.90%,GJC2;GJD3;GJC1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3979194374869123,0.8760993213130173,0.6325925925925926,0.9073007363207838,1.0,2/14,3.82%,CRYM;MTHFR
prerank,small GTPase binding (GO:0031267),0.286039679132705,0.8745001936016905,0.7242798353909465,0.9074422681231732,1.0,36/170,16.92%,ABCA1;MLPH;LRRK2;MYCBP2;RAPGEF4;FGD4;MYO5A;RABGAP1L;UNC13D;EXOC4;ABI2;MAPKAP1;GOLGA5;CHML;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;CCDC186;TBC1D20
prerank,peptide hormone receptor binding (GO:0051428),-0.35050484417307143,-0.8712190362696843,0.6242937853107344,0.9350200002340159,1.0,8/11,55.71%,PTHLH;ADCYAP1;CCK;GNRH1;PSMC5;UCN2;GPHB5;GHRH
prerank,peptide N-acetyltransferase activity (GO:0034212),0.41766795972270343,0.8681484145226108,0.6191198786039454,0.9164566942585116,1.0,2/10,15.11%,NAA50;NAA15
prerank,chemokine binding (GO:0019956),0.34472180742123454,0.867149635837634,0.6469072164948454,0.9155403364484931,1.0,4/30,12.48%,CCR1;CXCR4;PDPN;FGF2
prerank,aspartic-type peptidase activity (GO:0070001),0.4258384890367616,0.8663665602739119,0.6267496111975117,0.9143380829040496,1.0,2/10,13.92%,CTSD;PSEN1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3574750024488965,0.8655406767259303,0.636482939632546,0.913310389759612,1.0,12/27,24.09%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217
prerank,mannosyltransferase activity (GO:0000030),-0.28366283484461885,-0.8609266910956155,0.6496350364963503,0.9514864375943436,1.0,6/21,25.84%,TMTC1;PIGB;PIGZ;ALG1;PIGM;ALG12
prerank,ribonuclease activity (GO:0004540),0.3116891074645037,0.8583298056233066,0.6958579881656805,0.92315206687986,1.0,18/56,24.18%,ERN2;RNASE7;SMG6;EXOSC4;RNASEH1;DICER1;SND1;RNASEH2A;RNASE1;RNASE12;AGO2;ZC3H12B;ZC3H12A;EXOSC5;RNASE3;RNASEL;CPSF3;AGO1
prerank,tau protein binding (GO:0048156),0.3207058689634261,0.8537874592976228,0.6744471744471745,0.928431517420002,1.0,4/40,3.78%,TAOK1;SMAD2;MARK1;APOE
prerank,solute:sodium symporter activity (GO:0015370),0.34635384533355806,0.8534355323869821,0.6606683804627249,0.9264408489488396,1.0,4/27,10.23%,SLC28A2;SLC20A1;SLC13A5;SLC4A7
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2794751896225951,0.8530578370293782,0.8215725806451613,0.9245113329048795,1.0,48/248,17.54%,RND3;RHOJ;LRRK2;DNA2;RAB2A;KIF1C;MYH9;KIF2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RUVBL1;RNF213;ATP2B1;RHOA;RASD2;ENTPD7;ABCG4;RAB1A;DYNC2H1;GNAS;MYO1E;RAC1;GSPT1;RHOF;GPR88;GNB2;DHX29;GNA12;KIF5A;TPPP;RAB33B
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3530696896158894,0.8523299321710832,0.6765899864682002,0.9232043998641078,1.0,11/27,23.22%,TERT;CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,endoribonuclease activity (GO:0004521),0.33577694945518594,0.8517505798547778,0.6525759577278731,0.9216847650642545,1.0,11/32,24.18%,ERN2;SMG6;DICER1;SND1;AGO2;ZC3H12B;ZC3H12A;ENDOV;RNASEL;CPSF3;AGO1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3557715509719913,0.8507910307053733,0.6555090655509066,0.920847276929713,1.0,6/21,14.67%,ARFGEF2;GSKIP;ACBD3;PJA2;AKAP9;AKAP1
prerank,FAD binding (GO:0071949),0.3531515537856158,0.8505149359106638,0.6586666666666666,0.9187175571893389,1.0,2/24,3.82%,STEAP4;MTHFR
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.32800857485564056,-0.8473669725375906,0.6853932584269663,0.9737099797823623,1.0,2/12,7.53%,ENTPD1;SLC25A42
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3857103380998368,0.8456263281879834,0.6661654135338346,0.9245436715835207,1.0,7/14,19.90%,PTEN;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.30327515408530914,-0.8431203501133392,0.6987179487179487,0.9759680620298149,1.0,7/16,30.63%,MACROD2;CD38;SMUG1;SARM1;ADPRS;NEIL3;NTHL1
prerank,FMN binding (GO:0010181),-0.338183929649395,-0.8423015707337945,0.6676384839650146,0.9709598382364191,1.0,2/11,3.09%,NOS3;PPCDC
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3444397036186186,0.8422827426978797,0.6752368064952639,0.9276106882855661,1.0,7/24,16.10%,SESTD1;OSBPL5;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2918212272420414,-0.842087006183402,0.705685618729097,0.964864551534372,1.0,3/16,11.25%,SLC13A3;SLC1A1;SLC25A12
prerank,methyl-CpG binding (GO:0008327),0.35133572248959277,0.8406212041750182,0.6757493188010899,0.9279335366209932,1.0,8/22,23.63%,MBD2;MBD1;ZBTB38;CXXC5;LRWD1;MBD3;ZBTB33;PRMT5
prerank,store-operated calcium channel activity (GO:0015279),0.41302049784017786,0.8405084693495795,0.6623376623376623,0.9255630421792257,1.0,3/10,19.47%,TRPC6;ORAI1;STIM2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.32402899670981056,0.8404481597015296,0.7021013597033374,0.923125837655271,1.0,14/37,24.03%,YARS1;CARS2;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1;CARS1;DARS1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4146028415944501,0.8392801285992203,0.670906200317965,0.9225539698740295,1.0,1/10,2.07%,B4GALT5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.30326125032332407,-0.8389891836795813,0.6870503597122302,0.9649447051126449,1.0,4/15,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,potassium ion antiporter activity (GO:0022821),0.3822932104590235,0.8368959204181622,0.6617862371888726,0.9238246092975858,1.0,3/15,7.91%,SLC9A1;SLC24A5;SLC9A8
prerank,potassium:proton antiporter activity (GO:0015386),0.4089137619706108,0.836837243260742,0.6603174603174603,0.9214475339529429,1.0,2/10,7.91%,SLC9A1;SLC9A8
prerank,5'-3' exonuclease activity (GO:0008409),0.3785941024564651,0.8355409852189495,0.6724386724386724,0.9210550585362367,1.0,4/14,14.89%,DCLRE1C;DCP2;XRN1;DXO
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2562400803533681,-0.8341094011373996,0.723404255319149,0.9693860672664922,1.0,9/27,19.38%,SLC9A2;SLC8A3;SLC9B2;SLC4A8;SLC9A6;SLC9A7;SLC8B1;SLC9A5;SLC8A2
prerank,GTPase activity (GO:0003924),0.27493979121789647,0.8320658123551842,0.8178137651821862,0.9242150095615639,1.0,35/192,17.54%,RND3;RHOJ;LRRK2;RAB2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RHOA;RASD2;ENTPD7;RAB1A;GNAS;RAC1;GSPT1;RHOF;GNB2;GNA12;TPPP;RAB33B
prerank,TBP-class protein binding (GO:0017025),-0.27274818825948616,-0.8314728932915549,0.6523297491039427,0.9684512545960832,1.0,5/21,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,ATP hydrolysis activity (GO:0140603),-0.23183098028349824,-0.8295321941778018,0.746031746031746,0.9659000916032775,1.0,10/41,16.01%,HSP90AA1;SMCHD1;ABCA4;VWA8;MYO18A;ABCA3;CHD1L;KIF26A;ABCB10;TOR1A
prerank,lysophospholipase activity (GO:0004622),0.35466388471467053,0.8283884313054447,0.6896067415730337,0.927787664312073,1.0,6/20,19.58%,ASPG;ABHD16A;LYPLAL1;PLA2G4A;LYPLA2;GDPD3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3531708102488794,0.82645859284969,0.6803840877914952,0.9283139989798681,1.0,4/21,15.53%,POLE3;POLI;REV1;POLG
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3457985556686134,-0.8264339367437021,0.66,0.9658095214527064,1.0,6/10,20.16%,ATXN3;STAMBP;DESI2;CYLD;YOD1;OTUD4
prerank,titin binding (GO:0031432),-0.31481405907332405,-0.8260250977558122,0.6850152905198776,0.9603696519299402,1.0,2/13,2.77%,ACTN2;CALM1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3929273211571551,0.8251350225037474,0.6766917293233082,0.9280054398219695,1.0,2/11,15.11%,NAA50;NAA15
prerank,phosphatidylglycerol binding (GO:1901611),0.385760316390515,0.8240842409856372,0.6606875934230194,0.9272723028097418,1.0,2/13,4.28%,STOML2;PLTP
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.37697419727992365,0.8220055156880985,0.6911544227886057,0.9281858974222333,1.0,4/14,13.10%,ACO1;ACO2;SDHB;IREB2
prerank,tubulin binding (GO:0015631),0.2646021990500438,0.8182812814282142,0.8808808808808809,0.9317606435814385,1.0,61/296,19.52%,KIF26B;MID1;KIFC1;DLEC1;MAP4K4;TAOK1;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;HOOK2;KIF2A;INO80;RAE1;ALMS1;NCALD;PLK1;VAPA;MAST2;RABGAP1;EML3;FAM161A;TPGS1;TPX2;SETD2;GAPDH;MAPRE2;IFT81;CFAP157;AGTPBP1;MACO1;FMN1;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;WASHC1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3;CENPJ;BCAS3;HAUS6;PRNP;TBCEL;CAMSAP1;HOOK1
prerank,GABA receptor binding (GO:0050811),0.3907141891201713,0.817146986947923,0.6883942766295708,0.931137818555058,1.0,2/11,4.47%,TRAK1;ARFGEF2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.38552633662332103,0.8163294833225916,0.6964560862865947,0.9300047500837773,1.0,3/12,14.17%,IRS1;PIK3R1;GNAS
prerank,ribonuclease P RNA binding (GO:0033204),0.3969083169548041,0.8159763635976571,0.6779661016949152,0.9281328745633322,1.0,2/10,12.47%,POP1;POP4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3308622937729072,0.815726790158915,0.719029374201788,0.9260807794791066,1.0,5/28,12.47%,POP1;RNASEH1;DICER1;RNASEH2A;POP4
prerank,calcium channel activity (GO:0005262),0.2829688192685302,0.8145811205195186,0.7532894736842105,0.9253291468353274,1.0,15/84,17.18%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2;TRPC6;SLC24A5;TPCN2;SEC61A1;PSEN1;CATSPER3;TRPM4;ANXA6;PKD1L3;ORAI1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3227655544411409,-0.8115359523249297,0.7209944751381215,0.9829936182799985,1.0,8/11,54.73%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.31524987681945815,-0.8085432843957628,0.739946380697051,0.9822278416560342,1.0,4/12,23.12%,CNOT8;CNOT6L;TOE1;NOCT
prerank,phosphatidic acid binding (GO:0070300),0.35043966091724893,0.8069318141671546,0.6984352773826458,0.9344944709953432,1.0,4/19,7.85%,MARK1;PLTP;SESTD1;MAPKAP1
prerank,guanyl ribonucleotide binding (GO:0032561),0.2668185009310328,0.8055781132046671,0.8565615462868769,0.9341166591336586,1.0,31/196,15.01%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;PDE5A;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.305537893779132,-0.8052685522620995,0.7157190635451505,0.9819748705049508,1.0,4/13,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.39015368112104365,0.8039985221426282,0.6850393700787402,0.9341926153071541,1.0,2/10,11.05%,SLC10A6;SLC10A1
prerank,P-type ion transporter activity (GO:0015662),-0.32195941675375583,-0.8030183435395492,0.6988304093567251,0.9799199316580822,1.0,4/12,14.73%,ATP2B4;ATP2B2;ATP2A3;ATP6V1E1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3225824923757736,0.801450839783492,0.7323759791122716,0.9355860052050164,1.0,7/29,14.25%,SPRED1;CDKN2B;SPRED2;RPTOR;PRKAR1B;SPRY2;CDKN1B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.32702298627817467,-0.80135562294213,0.7068965517241379,0.9769199996728385,1.0,3/10,13.05%,PIK3R3;PIK3CB;PIK3CD
prerank,adenyl nucleotide binding (GO:0030554),0.3843076136899367,0.8007087037882139,0.6931818181818182,0.9319269018360988,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.3843076136899367,0.8007087037882139,0.6931818181818182,0.9319269018360988,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,ankyrin binding (GO:0030506),0.34336322733708496,0.7986245519482953,0.7142857142857143,0.9326506610366411,1.0,5/19,22.84%,FLNC;PTPRC;SPTBN1;SPTBN4;PLEC
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3308166653536624,0.7977724084117178,0.728744939271255,0.9315552439627668,1.0,4/23,10.87%,EDNRA;CCR1;CCL5;PLCB3
prerank,ATPase regulator activity (GO:0060590),0.30417893943887137,0.7930108026086232,0.7416974169741697,0.9358955395226026,1.0,9/38,18.43%,DNAJC1;DNAJB1;BAG3;FNIP1;DNAJB6;HSPH1;TOR1AIP2;BAG4;TOR1AIP1
prerank,transaminase activity (GO:0008483),-0.31473202407648526,-0.792485969617542,0.7435158501440923,0.9873632568207222,1.0,2/11,16.37%,ABAT;PSAT1
prerank,MHC protein binding (GO:0042287),-0.2651705055004055,-0.7891662073603318,0.7902097902097902,0.9873626583629482,1.0,5/20,28.94%,CD81;DERL1;TUBB4B;ABCB9;LAG3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.33925447719800206,0.7876529325970968,0.7386018237082067,0.9413963153479771,1.0,2/18,8.79%,HSD17B8;HSD11B1
prerank,intracellular chloride channel activity (GO:0061778),-0.27896698357334415,-0.7876150513336144,0.7638036809815951,0.9777610615107346,1.0,8/16,33.22%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.27896698357334415,-0.7876150513336144,0.7638036809815951,0.9777610615107346,1.0,8/16,33.22%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.31414464496125516,0.7872754359988743,0.7266839378238342,0.9396410316834487,1.0,4/28,9.84%,LRRK2;MAP2K4;MAP2K1;RPS6KB1
prerank,histone deacetylase activity (GO:0004407),-0.26442344937961926,-0.7861673249952331,0.7932203389830509,0.9740904292836268,1.0,3/19,5.69%,HDAC4;HDAC9;SUDS3
prerank,phospholipase binding (GO:0043274),-0.30304295351687716,-0.7859058212939124,0.7573099415204678,0.9685864588950038,1.0,4/13,18.52%,PRKN;BLNK;DGKQ;SYK
prerank,myosin V binding (GO:0031489),-0.28517449979453585,-0.7838845360107634,0.7603833865814696,0.9659954182523066,1.0,6/15,25.00%,RAB3C;RAB11B;RAB14;RAB39B;RAB3D;RAB3B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2589433148885322,-0.7837787620686153,0.775438596491228,0.9603031593767881,1.0,12/22,37.27%,ATP6V1B2;ATP2A3;ATP6V1E1;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP2C2;ATP6V0A4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.31140694999690294,0.781984051907968,0.7503152585119798,0.9449445728151312,1.0,15/33,26.67%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;TCERG1;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217;PPARA;RPS3
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.32801433307609257,0.781551630785577,0.7251051893408135,0.9431630079617963,1.0,3/20,7.16%,USP9X;OTULINL;EIF3H
prerank,calcium channel regulator activity (GO:0005246),-0.22852674285564123,-0.7815226875684381,0.8776595744680851,0.958206504331071,1.0,8/37,15.16%,NRXN1;CALM1;NRXN2;MCUB;CACNG7;PACSIN3;STIM1;FKBP1A
prerank,death receptor binding (GO:0005123),0.3537965076192608,0.7805487183075954,0.7230538922155688,0.9422120126080051,1.0,3/15,15.12%,CASP8AP2;EDA;RIPK1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.30972272321896444,-0.7801085575507456,0.7528409090909091,0.954712715958216,1.0,4/10,13.46%,BRCA2;EP300;HAT1;NAA60
prerank,voltage-gated cation channel activity (GO:0022843),0.2704216603115497,0.7794583505740348,0.8109289617486338,0.9413984368277687,1.0,8/97,5.01%,CACNA1A;HVCN1;CACNA2D1;CACNA1C;CACNB1;KCNF1;KCNA5;PKD2
prerank,protein phosphatase 1 binding (GO:0008157),0.332590249743111,0.7790935420552312,0.7414500683994528,0.9395493741462514,1.0,3/21,13.49%,PPP1R9B;PPP1R16A;AKAP11
prerank,protein kinase activator activity (GO:0030295),0.28319164630977206,0.7783376157707723,0.8064516129032258,0.938289315076961,1.0,13/60,16.20%,TAOK1;RICTOR;FAM20A;RPTOR;MAP2K1;TPX2;DBF4;SPRY2;FGF13;ABI1;CALM2;ALS2;STK4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.30295404752248534,0.7781223019602024,0.7458912768647282,0.936240948595933,1.0,7/32,12.31%,TMLHE;FTO;ALKBH5;HSPBAP1;ALKBH1;TET2;KDM2A
prerank,RNA methyltransferase activity (GO:0008173),-0.2637566565740106,-0.775248351239616,0.8074074074074075,0.9573030578773981,1.0,8/19,28.81%,TRMT9B;TRDMT1;METTL4;LCMT2;TRMT5;TYW3;TRMT12;FBL
prerank,symporter activity (GO:0015293),0.3752378814528862,0.7713893989300857,0.7445820433436533,0.9435242114826129,1.0,1/10,3.05%,SLC28A2
prerank,RNA stem-loop binding (GO:0035613),0.362158365919414,0.7691845521530678,0.7428571428571429,0.9443736251465067,1.0,5/12,21.08%,METTL16;FMR1;RC3H2;CSDE1;ZC3H12A
prerank,ribonuclease P activity (GO:0004526),0.3672903248338953,0.7685723648417536,0.7410852713178294,0.94290176065885,1.0,2/11,12.47%,POP1;POP4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3625051484126034,0.7663835200093893,0.7523076923076923,0.9435832537736476,1.0,2/11,11.72%,PABIR1;PPP1R2
prerank,sodium:proton antiporter activity (GO:0015385),0.36192539658395634,0.7651563270559616,0.7380585516178737,0.942940221642903,1.0,2/11,7.91%,SLC9A1;SLC9A8
prerank,BMP binding (GO:0036122),0.36252354048964214,0.764863636528456,0.7427258805513017,0.941093605308231,1.0,11/11,63.77%,GREM2;BMPR2;GREM1;NBL1;SOST;GDF5;HJV;UCMA;TCAP;SOSTDC1;ENG
prerank,endodeoxyribonuclease activity (GO:0004520),0.32207709896599973,0.763779091908481,0.7637130801687764,0.940258811226784,1.0,7/20,23.02%,DNA2;DCLRE1C;SETMAR;RBBP8;MBD4;ZRANB3;ENDOV
prerank,GTPase inhibitor activity (GO:0005095),-0.29862369862051374,-0.7621941607442543,0.772189349112426,0.9718360667754432,1.0,5/13,23.37%,CDC42SE1;GPS2;SLIT2;RHOH;ARL2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3359406939657822,0.7600404147008246,0.7769571639586411,0.9430052749284995,1.0,8/16,19.90%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,telomeric DNA binding (GO:0042162),0.2987816088707329,0.7579367530027289,0.7869897959183674,0.943434483164143,1.0,13/32,25.80%,SMG7;ZBTB48;TERT;SMG6;CTC1;KDM1A;TELO2;TERF1;RPA1;SMG5;TERF2IP;TERF2;HNRNPA2B1
prerank,sodium channel activity (GO:0005272),-0.2168892690094192,-0.756268877148306,0.9068627450980392,0.9752000104181933,1.0,11/37,27.71%,GRIK4;SCN2A;SCN8A;SCN9A;GRIK2;HCN1;SCN4B;CACNA1I;SHROOM2;SCN3A;PKD2L1
prerank,actin monomer binding (GO:0003785),0.3199892880297087,0.7551893355057142,0.7734265734265734,0.9448042992160779,1.0,2/22,4.59%,MRTFA;LIMA1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3320952141488613,0.751857042465357,0.7872044506258693,0.9468401665195281,1.0,5/18,15.64%,BAIAP2;ANXA1;CNN3;RAB10;CDC42EP1
prerank,protein kinase C binding (GO:0005080),0.2859184928677187,0.7502471339584561,0.8174123337363967,0.946722853014795,1.0,13/43,21.81%,IRS1;NELL1;PRKCSH;PRKD2;TIRAP;TOP2B;DACT1;SQSTM1;PLEK;HDAC5;ADAM9;HINT1;PKN1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.2960387050244956,-0.7497116316554285,0.8142857142857143,0.9786950616681032,1.0,6/12,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3365302875274676,0.7486624571094315,0.7699248120300752,0.946526409684651,1.0,3/14,21.28%,DTYMK;AK8;NME2
prerank,5'-nucleotidase activity (GO:0008253),-0.2954693816046953,-0.7486165954949225,0.8042813455657493,0.9745610183142581,1.0,5/13,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,phosphoric ester hydrolase activity (GO:0042578),0.27716238206529614,0.7481068657973333,0.8002364066193853,0.9449180042169047,1.0,9/49,15.26%,PDXP;PLCXD3;DUSP5;EPHX2;PTPRJ;PPP1CB;DUSP28;SACM1L;SMPDL3B
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.26453054610724547,0.7474149513657941,0.8456449834619625,0.9435756665446194,1.0,13/69,18.64%,CERS6;ASPG;CREBBP;SOAT1;HHAT;PLA2G4A;ZDHHC6;ZDHHC9;NAA15;PLA2G4E;ZDHHC3;LPCAT3;KAT6B
prerank,general transcription initiation factor binding (GO:0140296),-0.23595626990179808,-0.745971004928837,0.8661417322834646,0.9725609990615529,1.0,5/25,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,exoribonuclease activity (GO:0004532),-0.2918754931371521,-0.7453027037052363,0.8059299191374663,0.9679069552776112,1.0,5/12,22.00%,EXOSC7;EXOSC8;EXOSC3;EXOSC1;EXOSC10
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3551406915644517,0.7451654187522457,0.7598187311178247,0.9441884583450258,1.0,6/12,23.91%,ACVR1;TGFBR1;LTBP1;ACVRL1;BMPR1A;BMPR2
prerank,calcium channel inhibitor activity (GO:0019855),0.36437438971293756,0.7441750941923423,0.7805255023183926,0.9432151294013327,1.0,3/11,13.64%,ITPR1;FKBP1B;CALM2
prerank,protein phosphatase activator activity (GO:0072542),0.3447968412600075,0.7419368996424597,0.7795857988165681,0.9438101075468383,1.0,9/13,27.73%,PPP2R5A;CALM2;PTPA;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,nucleotidase activity (GO:0008252),-0.27483101724167924,-0.7381667540258301,0.8275862068965517,0.9723355217612036,1.0,5/15,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.29769890605346155,-0.7367993915099427,0.8245125348189415,0.9686484288768439,1.0,6/11,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,snoRNA binding (GO:0030515),0.292452754033528,0.7352929769938492,0.8036410923276983,0.9500314968046933,1.0,15/30,30.71%,NOP14;NUDT4;BYSL;PRKDC;NUDT7;DHX37;BMS1;DDX21;TSR1;NOP56;NUDT5;UTP6;TBL3;NUFIP1;HEATR1
prerank,deubiquitinase activity (GO:0101005),0.25322168512326315,0.7333914815781032,0.8638858397365532,0.9500633358671596,1.0,23/88,21.08%,TNFAIP3;USP9X;EIF3H;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14;USP36;MINDY4;USP21;USP25;ZC3H12A
prerank,omega peptidase activity (GO:0008242),0.2517486351735413,0.7331727704308983,0.8765027322404372,0.948059961381014,1.0,19/89,16.79%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;GGT7;USP28;GGH;PSMD14
prerank,voltage-gated chloride channel activity (GO:0005247),-0.2957709129173993,-0.7313598130346327,0.8086734693877551,0.9702728752314786,1.0,3/10,16.94%,CLCN2;CLCN3;ANO1
prerank,ATPase activator activity (GO:0001671),0.3156794731310358,0.7262312147058619,0.8027972027972028,0.9541803798434897,1.0,5/20,18.43%,DNAJC1;DNAJB1;DNAJB6;TOR1AIP2;TOR1AIP1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3249920914572677,0.7260962974537937,0.7832585949177877,0.9520766948999336,1.0,4/15,16.47%,PI4K2B;ATM;PI4KA;PIK3C3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2603960418492409,-0.726035295410729,0.8653846153846154,0.9719118846388182,1.0,3/15,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,fibroblast growth factor binding (GO:0017134),-0.24410006859564976,-0.7250240016008852,0.845360824742268,0.9677095352379195,1.0,7/21,22.81%,FGFR2;THBS1;FGFR4;KL;GPC1;RPS19;FGFBP3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.34862877760920274,0.7243209010356144,0.7880258899676376,0.951948154424037,1.0,4/10,14.92%,EHMT1;SETDB1;SETDB2;ASH1L
prerank,glycine binding (GO:0016594),0.34730092053481315,0.7201076091525942,0.7990654205607477,0.9548098485620198,1.0,2/11,6.35%,GLRB;GLDC
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2792770278216387,0.7192610142523769,0.8320512820512821,0.9535937265429755,1.0,10/34,22.02%,UBE2F;UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,carboxypeptidase activity (GO:0004180),-0.20577171145935524,-0.7191410388344908,0.8934010152284264,0.9696939957829803,1.0,9/35,21.50%,CPD;CPE;FOLH1;MINDY1;CPM;NAALAD2;AGBL5;ACE2;VASH1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.2906805429696572,-0.7171162023144183,0.8287292817679558,0.9668434095096762,1.0,4/10,23.64%,DCLRE1A;MGME1;DCLRE1B;TATDN1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3110145356264621,0.715072336454621,0.8046767537826685,0.956510888020895,1.0,4/19,13.22%,CCL5;EGF;EFNA5;ABI1
prerank,actin binding (GO:0003779),0.23610120088164196,0.7134280718781805,0.9245867768595041,0.9561710466080869,1.0,27/170,13.76%,SLC6A2;MRTFA;MLPH;LRRK2;SYNPO;CALD1;FSCN1;MYH9;PARVA;MAP1S;LIMA1;NCALD;FHL3;ADD2;TMOD1;PDLIM4;LCP1;CXCR4;DBN1;SSH1;PTK2;DBNL;UTRN;GIPC1;SSH2;MAEA;PLEKHH2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3300542407841866,0.7121145610529015,0.8147590361445783,0.9553833608151682,1.0,2/12,7.91%,SLC9A1;SLC9A8
prerank,kinesin binding (GO:0019894),0.2870311244399091,0.7094856732405405,0.8324468085106383,0.9561632001092325,1.0,2/27,6.19%,NEK6;IFT88
prerank,thiol-dependent deubiquitinase (GO:0004843),0.24512100998767508,0.7092963950416467,0.8806133625410734,0.9542029908145767,1.0,17/83,16.79%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.280359106833837,-0.7092461577695736,0.8563685636856369,0.9706412145992206,1.0,4/11,16.61%,SGMS1;SGMS2;AASDHPPT;PIGF
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2640175737144371,-0.7050278914538495,0.8664596273291926,0.9698150337820889,1.0,7/13,43.74%,LPIN1;PLPPR4;PLPP5;PLPP2;LPIN3;PLPP4;LPIN2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.2707087535650054,-0.6986981433953238,0.8195266272189349,0.9711058291410901,1.0,2/12,11.02%,CYFIP2;DCPS
prerank,adenylyltransferase activity (GO:0070566),-0.22499926140321497,-0.6958754690084343,0.9110320284697508,0.968611183897419,1.0,4/21,16.25%,GPHN;NMNAT3;TUT1;OAS2
prerank,metal ion:proton antiporter activity (GO:0051139),0.3172764621653848,0.6947171685706965,0.8330871491875923,0.968617306725641,1.0,2/13,7.91%,SLC9A1;SLC9A8
prerank,serotonin receptor activity (GO:0099589),0.2968539838346782,0.6945308269752413,0.85,0.9621384534504476,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,G protein-coupled amine receptor activity (GO:0008227),0.2968539838346782,0.6945308269752413,0.85,0.9621384534504476,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.2968539838346782,0.6945308269752413,0.85,0.9621384534504476,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,N-acyltransferase activity (GO:0016410),0.2708063455736607,0.693082387691552,0.8825806451612903,0.9615028908602476,1.0,2/32,4.17%,CERS6;NAA50
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2843383823487705,0.6907776679518816,0.8342175066312998,0.9617849472290413,1.0,10/27,23.22%,CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,U6 snRNA binding (GO:0017070),-0.25804494667425376,-0.689885172771138,0.8795180722891566,0.9694374302921049,1.0,5/14,23.76%,PRPF4;LARP7;TUT1;PRPF8;DDX39B
prerank,histone demethylase activity (GO:0032452),0.2820367472796702,0.6895494263744134,0.8331090174966352,0.960897548095154,1.0,9/27,26.60%,PHF2;KDM2A;FBXL19;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.29573676363706486,0.6885875611479045,0.8437935843793585,0.9598063608827347,1.0,1/18,2.96%,BIRC3
prerank,DNA polymerase binding (GO:0070182),-0.23764411161284127,-0.686874908440601,0.9,0.9672772116926516,1.0,4/18,14.10%,HSP90AA1;RTEL1;FANCI;PCNA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.32446587908801094,0.6862521245105531,0.8234398782343988,0.9601245476451898,1.0,2/12,10.07%,FXN;SDHB
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2540153394197169,0.6852303697180372,0.8877314814814815,0.9590677731665845,1.0,15/51,20.57%,SLC28A2;SLC20A1;SLC25A16;SLC7A8;SLC35C1;TMEM241;SLCO1B1;SLC35D2;SLCO4C1;SLC25A10;SLC28A3;SLC16A2;SLCO5A1;SLCO2B1;CLCN4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.32275705181673936,0.6852122506796828,0.8343653250773994,0.9569177305069441,1.0,4/11,20.43%,ALKBH1;HMCES;HMGA2;NEIL1
prerank,cation channel activity (GO:0005261),0.2349716818361325,0.6836560062416888,0.9238302502720348,0.9563400406650082,1.0,20/94,18.83%,HVCN1;KCNF1;PIEZO2;PKD2;TRPC6;SLC24A5;CALHM2;KCNK1;SEC61A1;PSEN1;UNC80;TRPM4;ANXA6;ANO10;KCNK9;PKD1L3;ORAI1;ANO6;PANX1;PIEZO1
prerank,ribosomal large subunit binding (GO:0043023),0.3230117264819873,0.6827556734395704,0.8370607028753994,0.9551442504374014,1.0,3/11,20.78%,NMD3;LTN1;NEMF
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.31396269514738373,0.6789511798194205,0.8411497730711044,0.9571285534935693,1.0,3/12,20.33%,TENT5A;PAPOLG;TENT4A
prerank,ribosomal small subunit binding (GO:0043024),0.30271789355077106,0.6780129197553458,0.8571428571428571,0.9559004975578468,1.0,4/17,16.98%,ABCE1;MTIF2;EIF1;DHX29
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.2841932282009415,-0.6776783355025683,0.8431952662721893,0.9705617776820528,1.0,2/10,10.15%,PHF8;RIOX2
prerank,O-acyltransferase activity (GO:0008374),0.2714490059543482,0.6747946898561548,0.8773946360153256,0.9569399745781048,1.0,5/30,17.16%,PIGW;SOAT1;GPAT3;PLA2G4A;LPCAT3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.21127937975439207,-0.6737631183208735,0.9404761904761905,0.9692320118152029,1.0,7/26,21.50%,CPD;CPE;FOLH1;CPM;AGBL5;ACE2;VASH1
prerank,calcium activated cation channel activity (GO:0005227),0.3005112109314587,0.6733736963800901,0.8626292466765141,0.9561860077128392,1.0,5/17,20.68%,KCNMB4;TRPM4;ANO10;ANO6;TMEM63B
prerank,dynactin binding (GO:0034452),-0.2655073204371194,-0.6729331798593772,0.8422459893048129,0.9649423436175892,1.0,1/12,0.78%,BICD1
prerank,phospholipase A2 activity (GO:0004623),0.2694159442521415,0.6669361387016419,0.8911022576361222,0.9604086391516077,1.0,4/26,15.97%,PLA2G7;PLA2G12A;PLA2G4A;PLA2G4E
prerank,NF-kappaB binding (GO:0051059),0.2723147171199542,0.6651153694911469,0.8668442077230359,0.9599429578031387,1.0,8/24,26.31%,PSMA6;HDAC1;GSK3B;COMMD7;NFKBIA;COMMD6;RELA;TAF4B
prerank,endonuclease activity (GO:0004519),0.24573736745634508,0.6647803820634268,0.9084249084249084,0.9581278607068595,1.0,14/49,24.18%,ERN2;SMG6;DICER1;SND1;SETMAR;PNKP;MBD4;AGO2;ZC3H12B;ZC3H12A;ZRANB3;RNASEL;CPSF3;AGO1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.32131270187156696,0.6645233401545552,0.8504672897196262,0.9562541850426457,1.0,2/11,13.58%,EGFR;MAP3K6
prerank,SUMO transferase activity (GO:0019789),0.29793385391642846,0.662592267025157,0.8686868686868687,0.9559149349745751,1.0,4/16,17.55%,PIAS2;NSMCE2;EGR2;MDM2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.19673331832126836,-0.6589243070303243,0.9590909090909091,0.9717926515072846,1.0,10/34,23.12%,CNOT8;EXOSC7;CNOT6L;EXOSC3;ANGEL2;TOE1;ANGEL1;PDE12;EXOSC10;NOCT
prerank,CoA-ligase activity (GO:0016405),-0.2515291991702716,-0.6588100909534682,0.8738738738738738,0.9668302731572166,1.0,3/14,20.01%,ACSL1;ACSS1;ACSS2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.25907417505101005,-0.6543014399601624,0.9147727272727273,0.9656377114420285,1.0,5/11,27.59%,STN1;HNRNPA1;RAD50;RPA2;NABP2
prerank,phosphatase activity (GO:0016791),0.22837951030596715,0.6460529044796226,0.9435215946843853,0.9687873571690101,1.0,9/73,13.66%,PDXP;DUSP5;EPHX2;NT5M;PTPRJ;PPP1CB;DUSP28;DUSP26;SACM1L
prerank,ion channel inhibitor activity (GO:0008200),0.2537501855214528,0.6453051245661193,0.9130982367758187,0.9673987882406144,1.0,7/35,16.40%,CAMK2D;ITPR1;FKBP1B;CALM2;KCNV1;NEDD4;RASA1
prerank,acid-thiol ligase activity (GO:0016878),-0.2463980502366897,-0.645112062198306,0.9169139465875371,0.9677005265007756,1.0,4/13,25.82%,ACSL1;ACSS1;ACSS2;AASDH
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2943816663320499,0.6429940509148858,0.8799392097264438,0.9673323581620122,1.0,2/14,7.63%,USP9X;MINDY3
prerank,adrenergic receptor binding (GO:0031690),0.2925590064092059,0.6401365687035088,0.9056047197640118,0.9677643241401818,1.0,4/16,15.60%,DLG4;ARRDC3;GNAS;NEDD4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.24651589361822063,-0.6282768046356231,0.9385474860335196,0.9741878284290131,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,damaged DNA binding (GO:0003684),0.2397382763420134,0.6281306640611859,0.9293544457978076,0.9757113336223474,1.0,9/44,20.29%,MPG;CREBBP;DCLRE1C;HMGB2;XRCC1;PNKP;DDB1;RBBP8;ERCC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23129473547755505,0.6281046573888514,0.945852534562212,0.973608666087924,1.0,6/54,9.69%,ASPG;MIER2;NADSYN1;NTAN1;HDAC1;PIGL
prerank,NADP binding (GO:0050661),0.2462291693720915,0.6263958565341532,0.922077922077922,0.9729445020963187,1.0,11/32,23.49%,CRYM;GMDS;HSD11B1;KCNAB1;DPYD;DECR1;MTRR;DUS2;QDPR;NDOR1;SPR
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.24810350420603353,0.6233869585756542,0.9379042690815006,0.9732748809369938,1.0,7/29,19.30%,HPSE;GAA;NEU3;GALC;NEU1;GANAB;MGAM
prerank,microtubule plus-end binding (GO:0051010),0.2620038835839052,0.6206847790359565,0.909972299168975,0.9733004595090142,1.0,10/20,28.84%,MAPRE2;FBXW11;CLIP3;DST;CLIP4;CLASP2;CLASP1;PAFAH1B1;CLIP2;MAPRE1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2449232944871971,0.6200638583259541,0.934640522875817,0.9717148108851861,1.0,9/31,22.02%,UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,acetyltransferase activity (GO:0016407),0.24785125062052116,0.619475503901867,0.9274292742927429,0.9700548900902051,1.0,5/31,18.64%,NAA50;CREBBP;NAT10;NAA15;KAT6B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.29700122587361794,0.6189813528572157,0.8928571428571429,0.9683636572986445,1.0,4/11,23.63%,CARM1;PRMT3;NDUFAF7;PRMT5
prerank,NADPH binding (GO:0070402),0.2839945580950651,0.6130014872084018,0.9054652880354506,0.9709006058380663,1.0,6/13,22.55%,KCNAB1;DECR1;MTRR;DUS2;QDPR;NDOR1
prerank,Hsp90 protein binding (GO:0051879),0.23824660812980503,0.6100234861221782,0.9380421313506815,0.9709047983604454,1.0,8/33,19.70%,PPID;AHR;CYP1A1;CSNK2A1;HIF1A;NPAS2;NR3C1;TELO2
prerank,rRNA binding (GO:0019843),0.22523914480799975,0.608512267489657,0.9600997506234414,0.9698657758988946,1.0,10/42,19.35%,ERI1;MTERF4;DDX28;GTF3A;RPL12;MRPS18A;RPL11;MDM2;RPS9;MRPS27
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.26179000590481943,0.6081054307768526,0.9187592319054653,0.9680710004616483,1.0,2/17,12.34%,DTYMK;AK8
prerank,nuclear export signal receptor activity (GO:0005049),0.2906312838013606,0.6049593494674365,0.8888888888888888,0.9681552286430093,1.0,5/11,26.00%,XPO7;NUP214;XPO1;RANBP17;NUP42
prerank,voltage-gated sodium channel activity (GO:0005248),0.2555749557761183,0.6032986977136079,0.9214876033057852,0.9672225056918013,1.0,2/22,5.83%,PKD2;SCN7A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.276940839431297,0.5983143739147545,0.8984615384615384,0.9687192266942299,1.0,2/13,9.90%,METTL1;THUMPD3
prerank,lipid phosphatase activity (GO:0042577),0.2767894171146738,0.5960151316141244,0.9093610698365527,0.9682685528680741,1.0,1/14,4.96%,EPHX2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.20559956315869124,-0.5912747032734705,0.9640287769784173,0.9904955581706396,1.0,10/18,34.39%,PIK3R3;PIK3R6;PIK3R2;SOCS7;SOCS2;SOCS3;CCKBR;AGAP2;SOCS1;CISH
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.22794385767448305,0.5875294171733182,0.9649805447470817,0.9715171312096771,1.0,4/33,11.16%,ERI1;EXOSC4;DCP2;XRN1
prerank,water transmembrane transporter activity (GO:0005372),0.27571579109433536,0.5852075551532622,0.9213836477987422,0.9708862125551216,1.0,1/11,11.38%,PDPN
prerank,nuclear import signal receptor activity (GO:0061608),0.26793908135725003,0.5850675966650702,0.9262536873156342,0.968935792709296,1.0,4/15,23.09%,KPNA3;TNPO1;KPNA2;KPNB1
prerank,transferrin receptor binding (GO:1990459),-0.24385277703646435,-0.5830619388768921,0.9439775910364145,0.9893436080004363,1.0,1/10,2.25%,CD81
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2216089056665394,-0.5811379775487372,0.956386292834891,0.9851606361061782,1.0,4/14,23.68%,MICAL1;NCF2;NOX1;CYB5R4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.25417986857176744,0.5795253503625725,0.9385714285714286,0.9701667523212743,1.0,4/17,22.83%,ACOT13;ACOT9;THEM4;ACAA2
prerank,acetylcholine receptor activity (GO:0015464),-0.1859147183117003,-0.5639062693475403,0.966542750929368,0.9869630082614113,1.0,1/22,1.10%,CHRM2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21182168814257088,0.5561378375294327,0.9779411764705882,0.980036252144369,1.0,8/40,20.89%,ASMT;THUMPD3;DNMT3B;PCMT1;COMT;SETD3;THUMPD2;N6AMT1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.22468246831475008,-0.5435720078407426,0.9719887955182073,0.9886658747155899,1.0,8/11,42.95%,KCNN2;KCNN3;KCNMB2;PKD2L1;KCNN4;KCNN1;KCNU1;KCNMB1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.25823717274899527,0.5426036989715144,0.9507462686567164,0.9840375868001896,1.0,3/12,21.40%,SPPL3;PSEN1;HM13
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.22456868519695228,-0.5324231536718992,0.9727520435967303,0.9871921334492798,1.0,7/10,47.46%,NCF2;NOX1;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.25719512388857463,0.5280780726699494,0.9655712050078247,0.9876734274181267,1.0,3/11,17.85%,DCP2;NUDT4;NUDT7
prerank,MHC class I protein binding (GO:0042288),-0.20077850326469113,-0.5279538027180828,0.98,0.983598329256473,1.0,13/13,79.94%,DERL1;TUBB4B;ABCB9;LILRB1;ATP5F1B;TAP2;TUBB;PILRA;CD8A;TAPBP;CD8B;TAP1;ATP5F1A
prerank,tRNA binding (GO:0000049),0.1974924147589408,0.5264849276304973,0.9817073170731707,0.9862697269854721,1.0,9/43,20.78%,XPOT;AIMP1;TERT;ALKBH1;NAT10;ELP1;MRPS27;FARS2;NEMF
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2114183200838164,0.5112402396103856,0.9756446991404012,0.9892574266739412,1.0,3/24,14.09%,CAMK2D;PHKA2;MKNK1
prerank,snRNA binding (GO:0017069),0.1876950013152,0.4922375194577398,0.9924337957124842,0.9926086904323401,1.0,9/42,19.40%,NCBP2;SNRNP35;SNRPB2;RNPC3;PRPF31;CCNT1;LSM7;CDK9;EFTUD2
prerank,RNA cap binding (GO:0000339),0.21836259966165406,0.49021697164014566,0.9813486370157819,0.9910849309411542,1.0,2/16,10.14%,EIF4A1;NCBP2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.22328683643204067,0.4901909841582091,0.9770444763271162,0.9890553600587736,1.0,3/15,13.29%,PIK3R5;SOCS5;PIK3R1
prerank,microtubule minus-end binding (GO:0051011),0.21625046544653814,0.460306139185905,0.9851411589895989,0.9929012963495845,1.0,3/13,19.33%,CAMSAP2;TUBGCP4;CAMSAP1
prerank,RNA polymerase binding (GO:0070063),0.1629385958082528,0.37281149579689415,0.9985486211901307,0.9988795821227668,1.0,4/18,21.59%,CCNT1;NEDD4;TCERG1;PHRF1
